000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1393|2994|lyfalmen|V0045|1689|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1393||1393|2994||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29996|39055|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||29996||29996|39055||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|45074|57752|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||45074||45074|57752||2 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|9678|14397|lyfalmen|V0457|6582|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||9678||9678|14397||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|28206|38217|lyfalmen|V0475|14152|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28206||28206|38217||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|36683|48939|lyfalmen|V0540|19911|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||36683||36683|48939||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4342|6192|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4342||4342|6192||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4228|8192|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4228||4228|8192||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|11629|16280|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11629||11629|16280||1 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|14774|21228|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||14774|21228||1 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|29340|39651|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||29340|39651||1 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999|30.04.2015|R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4210|6871|lyfalmen|||1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4210||4210|6871||1 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3102|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3102||1 000530|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|25556|34865|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||25556||25556|34865||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4448|7199|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4448||4448|7199||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2889|5053|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2889||2889|5053||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|14236|19513|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||14236||14236|19513||2 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2804|4936|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2804||2804|4936||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|KAB|0|0|0|100|DKK|34449|44577|lyfsjukr|||1|6000|0||Icepharma hf|Fresenius Kabi AB|Fitusambönd||34449||34449|44577||2 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3452|5828|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3452||3452|5828||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|95178|119881|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||95178||95178|119881||2 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20402|27158|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20402||20402|27158||1 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|4951|7060|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4951||4951|7060||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1332|2910|lyfalmen|V0037|1821|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1332||1332|2910||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5818|9084|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5818||5818|9084||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15424|22050|lyfalmen|V0115|13464|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||15424||15424|22050||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1948|3758|lyfalmen|V0050|2461|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1948||1948|3758||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|24755|32556|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||24755||24755|32556||1 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.10.2011|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|||lyfalmen|||2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||||||| 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5587|8766|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5587||5587|8766||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3457|5835|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3457||3457|5835||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2177||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|4026|lyfalmen|V0039|3829|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2143||2143|4026||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20110|26796|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||20110||20110|26796||2 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|16177|23003|lyfalmen|V0637|20385|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||16177||16177|23003||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27875|36425|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||27875||27875|36425||2 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2217|3161|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2217||2217|3161||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4609|7420|lyfalmen|V0444|7420|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||4609||4609|7420||1 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|þpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|733|2085|lyfalmen|V0004|550|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||733||733|2085||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2315||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|7958|lyfalmen|V0297|6720|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||5000||5000|7958||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3754|6243|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3754||3754|6243||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|3760|lyfalmen|V0292|3760|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3760||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3816|6329|lyfalmen|V0004|2199|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3816||3816|6329||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|6307|lyfalmen|V0296|5343|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3800||3800|6307||1 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7577|11505|lyfalmen|V0011|2928|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7577||7577|11505||1 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|þpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1203|2732|lyfalmen|V0005|610|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1203||1203|2732||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5340|8426|lyfalmen|V0005|2440|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5340||5340|8426||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4282|6970|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4282|6970||2 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4676|7512|lyfalmen|V0011|2614|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4676||4676|7512||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23486|30983|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||23486||23486|30983||2 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8517|12799|lyfalmen|V0012|2636|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8517||8517|12799||1 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2861|5014|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2861||2861|5014||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15698|22397|lyfalmen|V0492|3497|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||15698||15698|22397||1 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|81893|103407|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||81893|103407||2 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|41743|53621|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||41743|53621||2 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|21251|28211|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||21251|28211||2 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2041|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2307||1 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3029|5221|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3029||3029|5221||2 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1157|2669|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1157||1157|2669||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|23270|30715|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||23270||23270|30715||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12974|14342|lyfalmen|V0089|2656|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9638||9638|14342||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|9590|14276|lyfalmen|V0515|4082|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||9590||9590|14276||1 003099|L01DB0104|Myocet|irþ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|183832|229812|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||183832||183832|229812||2 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|16312|23173|lyfalmen|V0253|6532|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||16312||16312|23173||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|31655|42579|lyfalmen|V0516|5446|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||31655||31655|42579||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|9015|13485|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||9015||9015|13485||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|13402|19493|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||13402||13402|19493||1 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007|30.04.2015|R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|188743|235901|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||188743||188743|235901||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6221|9639|lyfalmen|V0356|8715|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6221||6221|9639||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5833|9105|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5833||5833|9105||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2965|5157|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2965||2965|5157||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|2042|3887|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||2042||2042|3887||1 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|G|0|SIV|0|0|1|100|DKK|825|2212|lyfalmen|||1|10|0|10,0000|Vistor hf|Bayer AB|Pseudóefedrín í blöndum||825||825|2212|31.3.2015|1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|1719|lyfalmen|V0151|1647|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||467||467|1719||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|541|1821|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||541||541|1821||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2560|lyfalmen|V0322|2296|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2560||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1961|3775|lyfalmen|V0469|1902|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1961||1961|3775||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|17451|23499|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||17451||17451|23499||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7297|11120|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7297||7297|11120||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4389|7117|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4389||4389|7117||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|546|1828|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||546||546|1828||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1049|2520|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1049||1049|2520||1 004184|L03AC0101|Proleukin|stl/irs|||1|hgl|1|pakki||L03AC01|01.10.2013||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|30068|39144|lyfsjukr|||1|1|0|5,5000|Vistor hf|Novartis Healthcare A/S|Aldesleukín||30068||30068|39144||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5046|8022|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5046||5046|8022||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7419|11288|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||7419||7419|11288||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|10294|15245|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||10294||10294|15245||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|19421|25942|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||19421||19421|25942||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|5812|5218|lyfalmen|V0381|3799|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3009||3009|5218||1 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001|28.02.2015|R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4127|6757|lyfalmen|||1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4127||4127|6757||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|7094|13629|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||7094||7094|13629||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2994|5197|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2994||2994|5197||2 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980|31.03.2015|R|1|0|0|0|G|0|REP|0|0|0|100|SEK|566|1855|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||566||566|1855||1 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3993|6572|lyfalmen|V0226|2656|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3993||3993|6572||2 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7506|11408|lyfalmen|V0228|4902|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7506||7506|11408||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2326|4278|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||2326||2326|4278||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2906|2617|lyfalmen|V0494|2617|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||1119||1119|2617||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|2666|lyfalmen|V0318|2177|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1155||1155|2666||1 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002|31.03.2015|R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|31804|41297|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||31804||31804|41297||2 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1744|3477|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1744||1744|3477||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3434|5803|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefnavakar||3434||3434|5803||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|5164|lyfalmen|V0320|4793|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5164||1 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1782|lyfalmen|V0062|1647|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|2560|lyfalmen|V0317|2560|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1078||1078|2560||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1782|lyfalmen|V0067|1647|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1782||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1803||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|34473|44607|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||34473||34473|44607||3 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3524|lyfalmen|V0318|1219|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3524||1 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002|31.03.2015|R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|159020|199045|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||159020||159020|199045||2 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|8622|12944|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8622||8622|12944||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|774|2142|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||774||774|2142||1 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|2392|lyfalmen|V0282|2392|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||956||956|2392||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4993|7120|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4993||4993|7120||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|344|1550|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||344||344|1550||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|678|2010|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||678||678|2010||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1144|2651|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1144||1144|2651||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1884|3669|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1884||1884|3669||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3351|5689|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3351||3351|5689||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|18843|26375|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||||18843|26375||1 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8107|6758|lyfalmen|V0148|3575|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4128||4128|6758||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3053|5278|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||3053||3053|5278||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2353|4315|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2353||2353|4315||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2920|5095|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2920||2920|5095||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18661|26144|lyfalmen|V0356|26144|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18661||18661|26144||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2946|5131|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2946||2946|5131||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|52367|68776|lyfalmen|V0451|64696|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||52367||52367|68776||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1649|3346|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1649||1649|3346||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5618|8809|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5618||5618|8809||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5905|9204|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5905||5905|9204||1 005606|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4633|7453|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4633||4633|7453||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1723|3448|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1723||1723|3448||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3445|5818|lyfalmen|V0020|1578|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3445||3445|5818||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|8987|13446|lyfalmen|V0020|4735|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||8987||8987|13446||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4494|7262|lyfalmen|V0020|2368|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4494||4494|7262||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6125|8590|lyfalmen|V0324|3336|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5459||5459|8590||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|16593|28600|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||16593||16593|28600||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9739|13343|lyfalmen|V0325|3537|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||8912||8912|13343||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2538|4570|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2538||2538|4570||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15078|19559|lyfalmen|V0326|4936|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||13454||13454|19559||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|þpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3290|5605|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3290||3290|5605||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|IKR|1816|1968|lyfalmen|V0169|1968|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|1968||2 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|76881|97192|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||76881||76881|97192||1 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5328|8410|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5328||5328|8410||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|92458|116508|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||92458||92458|116508||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5169|8191|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5169||5169|8191||1 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|144436|180961|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||144436||144436|180961||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|70636|89449|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||70636||70636|89449||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2253|4177|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2253||2253|4177||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3285|6403|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3285|6403||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|6954|10648|lyfalmen|||1|5|0|10,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||6954||6954|10648||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13195|19231|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13195||13195|19231||1 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|448477|557971|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||448477||448477|557971||1 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13496|19612|lyfalmen|V0099|3784|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||13496||13496|19612||1 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3982|6557|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3982||3982|6557||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12040|17770|lyfalmen|V0117|7761|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12040||12040|17770||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17781|25031|lyfalmen|V0118|12441|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17781||17781|25031||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2372|4341|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2372||2372|4341||1 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7548|11465|lyfalmen|V0194|9355|1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7548||7548|11465||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|22292|30737|lyfalmen|V0195|24802|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22292||22292|30737||1 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002|30.04.2015|R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|149233|186909|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||149233||149233|186909||2 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002|30.04.2015|R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|284784|354992|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||284784||284784|354992||2 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005|31.03.2015|R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|2657|4733|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2657||2657|4733||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|89244|112523|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||89244||89244|112523||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|228527|285233|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||228527||228527|285233||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2977|5174|lyfalmen|V0374|4177|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2977||2977|5174||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|7569|10793|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||7569||7569|10793||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|103908|130706|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||103908||103908|130706||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|21524|28550|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||21524||21524|28550||1 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1814|3127|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1814||1814|3127||2 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5756|8999|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5756||5756|8999||1 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4141|5905|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4141||4141|5905||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|228765|285529|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||228765|285529||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5910|9211|lyfalmen|V0618|5894|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||5910||5910|9211||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|20062|27916|lyfalmen|V0589|12977|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||20062||20062|27916||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|2453|lyfalmen|V0290|2384|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2453||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3688|6152|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3688||3688|6152||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1472|3102|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1472||1472|3102||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|þpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2080|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráð|Betametasón||729||729|2080||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|350|1558|lyfalmen|V0502|860|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||350||350|1558||2 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5075|8062|lyfalmen|V0620|5729|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5075||5075|8062||1 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1411|3018|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1411||1411|3018||1 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|597|1898|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||597||597|1898||1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|825|2212|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||825||825|2212||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1347|2930|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1347||1347|2930||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2663|4742|lyfalmen|V0226|4742|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2663||2663|4742||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|4229|6897|lyfalmen|V0227|6897|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||4229||4229|6897||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|5955|8754|lyfalmen|V0228|8754|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5578||5578|8754||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|134650|168826|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||134650||134650|168826||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|478|1734|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||478||478|1734||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|628|1932|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||622||622|1932||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5353|9226|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5353||5353|9226||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9974|19093|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9974||9974|19093||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|2235|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||2235||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2663|4742|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2663||2663|4742||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|95306|120039|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||95306||95306|120039||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|98869|124458|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||98869||98869|124458||2 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1784|3532|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1784||1784|3532||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6529|10063|lyfalmen|V0145|9458|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6529|10063||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12946|18916|lyfalmen|V0145|18916|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12946|18916||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1620|2848|lyfalmen|V0064|2741|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||1287||1287|2848||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4424|5481|lyfalmen|V0064|5481|2|60|0|60,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5481||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7324|10444|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7324||7324|10444||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3988|4852|lyfalmen|V0063|4852|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíð||2743||2743|4852||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|Medical ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7324|10444|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7324||7324|10444||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|13175|19206|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13175||13175|19206||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7324|10444|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7324||7324|10444||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|48061|61456|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||48061||48061|61456||1 009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||1848||2 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5036|8008|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5036||5036|8008||1 009340|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1051|2523|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1051||1051|2523||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1159|2672|lyfalmen|||1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1159||1159|2672||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1341|2922|lyfalmen|||1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1341||1341|2922||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1680|3389|lyfalmen|||1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1680||1680|3389||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6159|8783|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6159||6159|8783||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6853|9772|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6853||6853|9772||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6159|8783|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6159||6159|8783||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|174059|217693|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||174059||174059|217693||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4866|7774|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4866||4866|7774||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|52086|66447|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||52086||52086|66447||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8728|13090|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8728||8728|13090||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9234|13786|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9234||9234|13786||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8130|12266|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8130||8130|12266||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9234|13786|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9234||9234|13786||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7964|12038|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7964||7964|12038||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8122|12255|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8122||8122|12255||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1141|1967|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1141||1141|1967||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2002|3832|lyfalmen|V0329|1765|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2002||2002|3832||1 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003|30.04.2015|R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5712|8938|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5712||5712|8938||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|186809|233503|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||186809||186809|233503||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|6300|8984|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6300||6300|8984||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|11830|17359|lyfalmen|V0331|2590|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11830||11830|17359||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|16681|23640|lyfalmen|V0304|8747|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||16681||16681|23640||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dæluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|13186|19220|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13186|19220||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|21375|29577|lyfalmen|V0605|6261|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||21375||21375|29577||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|11564|16993|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||11564||11564|16993||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5783|9036|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5783|9036||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8491|12108|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8491||8491|12108||2 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1161|2674|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1161||1161|2674||2 010705|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005|31.03.2015|R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|7822|11843|lyfalmen|||1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||7822||7822|11843||1 010716|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2848|lyfalmen|V0006|1990|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2848||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|APC|0|0|0|100|NOK|11916|5119|lyfalmen|V0207|2310|1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2937||2937|5119||1 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|316732|394608|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||316732||316732|394608||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|316732|394608|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||316732||316732|394608||3 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|43006|55187|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||43006||43006|55187||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2681|3823|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2681||2681|3823||1 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2700|3554|lyfalmen|V0058|3554|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Felódipín||1800||1800|3554||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18666|26151|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18666||18666|26151||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|18448|25875|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18448||18448|25875||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3200|4930|lyfalmen|V0059|4930|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Felódipín||2800||2800|4930||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31781|42739|lyfalmen|V0683|28574|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31781||31781|42739||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31565|42465|lyfalmen|V0684|28412|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31565||31565|42465||1 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|16283|23137|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníð||16283||16283|23137||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4169|6815|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4169||4169|6815||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4332|7039|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4332||4332|7039||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|18757|24799|lyfalmen|V0327|5935|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||17597||17597|24799||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1106|2599|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1106||1106|2599||1 011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|7436|6582|lyfalmen|V0457|6582|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||4000||4000|6582||2 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|984|2431|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||984||984|2431||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2715|3257|lyfalmen|V0069|2943|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1584||1584|3257||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6138|9525|lyfalmen|V0357|8611|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||6138||6138|9525||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|5814|8619|lyfalmen|V0691|7818|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5480||5480|8619||1 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2136|3046|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2136||2136|3046||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|7575|9108|lyfalmen|V0624|8341|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5835||5835|9108||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1787|3512|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1787||1787|3512||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4354|6209|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4354||4354|6209||1 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|með skammtadælu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1129|2630|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1129||1129|2630||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|59394|75509|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||59394||59394|75509||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2482|4878|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2482||2482|4878||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1796|2124|lyfalmen|V0152|2124|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2124||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|3909|lyfalmen|V0323|3551|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3909||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3892|5550|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3892||3892|5550||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2154|3072|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2154||2154|3072||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7384|11240|lyfalmen|V0604|2970|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7384|11240||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|26054|34167|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||26054||26054|34167||1 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1216|1723|lyfalmen|V0551|1723|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||470||470|1723||2 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4186|6838|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||4186||4186|6838||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6282|9723|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6282||6282|9723||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1731|1872|lyfalmen|V0556|1872|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||578||578|1872||2 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|9446|10106|lyfalmen|V0622|9325|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6560||6560|10106||1 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|þpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3648|3021|lyfalmen|V0552|2957|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1413||1413|3021||2 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2065|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2065||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4129|6759|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4129||4129|6759||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|6057|9413|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6057||6057|9413||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2587|3700|lyfalmen|V0250|3700|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||1906||1906|3700||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3387|4239|lyfalmen|V0251|4239|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2298||2298|4239||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|5444|8569|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5444||5444|8569||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6440|12388|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6440||6440|12388||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|8806|13197|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8806||8806|13197||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1621|3186|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1621||1621|3186||2 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|6189|8826|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6189||6189|8826||2 013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004|28.02.2015|R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|28657|37395|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Pfizer Limited|Storkuþáttur IX||28657||28657|37395||1 013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004|28.02.2015|R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|48504|62005|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||48504||48504|62005||1 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|3116|4614|lyfalmen|V0042|4614|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2570||2570|4614||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4230|8196|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4230||4230|8196||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9870|18896|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9870||9870|18896||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1035|2034|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1035||1035|2034||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|125285|157213|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||125285|157213||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|322362|349844|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||280632||280632|349844||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|81893|103407|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||81893|103407||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1216|2750|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1216||1216|2750||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1610||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|706|1621|lyfalmen|V0562|1621|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||396||396|1621||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2325|4276|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2325||2325|4276||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|360|1572|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||360||360|1572||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4341|7051|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4341||4341|7051||1 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2749|lyfalmen|V0168|2665|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2749||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5736|8971|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5736||5736|8971||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2389|4365|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2389||2389|4365||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4284|6973|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4284||4284|6973||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|153486|192183|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||153486||153486|192183||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|312185|388969|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||312185||312185|388969||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2312|4259|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2312||2312|4259||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7074|10088|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7074||7074|10088||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|16774|23758|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16774||16774|23758||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|62755|81915|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||62755||62755|81915||2 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|18415|25833|lyfalmen|V0357|25833|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||18415||18415|25833||1 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1505|3148|lyfalmen|V0676|3148|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1505||1505|3148||2 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|340|1544|lyfalmen|V0563|1544|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||340||340|1544||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2132|4011|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Metrónídazól||2132||2132|4011||1 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2124|4175|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2124|4175||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|76487|96704|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||76487|96704||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5280|10188|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5280||5280|10188||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|857|1714|lyfalmen|V0564|1714|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||463||463|1714||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1170|2687|lyfalmen|V0596|1854|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||1170||1170|2687||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1044|2257|lyfalmen|V0558|2109|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||858||858|2257||2 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1218|2187|lyfalmen|V0559|2177|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||807||807|2187||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|17849|25117|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||17849||17849|25117||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|53861|70665|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||53861||53861|70665||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|35852|47888|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||35852||35852|47888||1 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2529|4187|lyfalmen|V0673|3691|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2260||2260|4187||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7953|12023|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7953||7953|12023||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|þpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1025|2466|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1010||1010|2466||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4875|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráð|Betametasón||2760||2760|4875||3 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1008|2464|lyfalmen|||1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1008||1008|2464||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2051|2681|lyfalmen|V0234|1910|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1166||1166|2681||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2929|2681|lyfalmen|V0233|2190|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1166||1166|2681||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|9475|14118|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9475||9475|14118||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|294053|366486|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||294053||294053|366486||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|84490|106628|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||84490||84490|106628||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4913|7839|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4913||4913|7839||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12491|18341|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12491||12491|18341||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4913|7839|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4913||4913|7839||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13503|19621|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13503||13503|19621||1 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65167|82667|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65167||65167|82667||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4913|7839|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4913||4913|7839||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12359|18174|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12359||12359|18174||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|65167|82667|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||65167||65167|82667||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20896|28971|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||20896||20896|28971||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|43526|57594|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||43526||43526|57594||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2963|5107|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2963||2963|5107||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4867|8389|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4867||4867|8389||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2210|3809|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2210||2210|3809||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3083|5314|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3083||3083|5314||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4657|8027|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4657||4657|8027||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1862|3639|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1862|3639||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2091|3954|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2091||2091|3954||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1662|3364|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1662||1662|3364||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2964|5109|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2964||2964|5109||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2122|3997|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2122||2122|3997||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1235|2776|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1235||1235|2776||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1309|2878|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1309||1309|2878||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2530|4559|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2530||2530|4559||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6595|10154|lyfalmen|V0686|8784|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6595||6595|10154||1 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004|28.02.2015|R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4556|7347|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4556|7347||2 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9998|14838|lyfalmen|V0687|13464|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||9998||9998|14838||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1671|3376|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1671||1671|3376||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14530|20920|lyfalmen|V0689|19351|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||14530||14530|20920||1 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8185|12342|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||8185||8185|12342||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|89068|112304|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||89068||89068|112304||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3484|4968|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3484||3484|4968||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2601|4656|lyfalmen|V0685|4077|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2601||2601|4656||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|16269|23119|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16269||16269|23119||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7423||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|31781|42739|lyfalmen|V0682|28574|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||31781||31781|42739||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2128|lyfalmen|V0169|1687|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||764||764|2128||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|134307|168401|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||134307||134307|168401||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|6951|10644|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6951||6951|10644||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2839|4984|lyfalmen|V0240|4984|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2839||2839|4984||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5240|8289|lyfalmen|V0433|8289|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5240||5240|8289||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|56694|74249|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||56694||56694|74249||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|83538|108201|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||83538||83538|108201||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|26996|36687|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||26996||26996|36687||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|66622|84471|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||66622||66622|84471||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3295|5612|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3295|5612||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|36672|46878|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||36305||36305|46878||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2919|5094|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2919||2919|5094||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17436|33250|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17436||17436|33250||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1420|3031|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1420||1420|3031||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|245121|305810|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||245121||245121|305810||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|6281|9721|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||6281||6281|9721||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|AGT|0|0|0|100|SEK|5674|8886|lyfalmen|||2|500|0|500,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5674||5674|8886||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|136000|170500|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||136000||136000|170500||1 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31719|41192|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||31719||31719|41192||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|104555|131508|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||104555||104555|131508||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|44463|58779|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||44463||44463|58779||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|138076|177181|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||138076||138076|177181||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|5250|8302|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||5250||5250|8302||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|9648|14356|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||9648||9648|14356||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|8215|11715|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8215||8215|11715||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|951|2385|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||951||951|2385||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2645|4717|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2645||2645|4717||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2665|lyfalmen|V0168|2665|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2665||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6223|11977|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6223||6223|11977||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9686|14408|lyfalmen|V0197|11812|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||9686||9686|14408||1 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|38332|51024|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||38332||38332|51024||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8845|13251|lyfalmen|V0107|6444|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8845||8845|13251||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3559|5975|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3559||3559|5975||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3834|6353|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3834||3834|6353||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1707|lyfalmen|V0243|1367|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1707||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|7696|11669|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||7696||7696|11669||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|12708|17618|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||12708||12708|17618||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|18869|26408|lyfalmen|V0441|21339|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||18869||18869|26408||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|854|2252|lyfalmen|V0414|2154|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||854||854|2252||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5450|8578|lyfalmen|V0438|7051|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5450||5450|8578||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|15363|21973|lyfalmen|V0440|17837|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||15363||15363|21973||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|31972|42980|lyfalmen|V0111|25153|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||31972||31972|42980||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|91696|115563|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||91696||91696|115563||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|63652|80788|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||63652||63652|80788||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1080|2123|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1080||1080|2123||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|9021|13493|lyfalmen|V0221|7263|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||9021||9021|13493||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|6529|9310|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||6529||6529|9310||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6448|9951|lyfalmen|V0220|5651|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6448||6448|9951||1 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19846|26469|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||19846||19846|26469||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3575|5997|lyfalmen|V0219|3356|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3575||3575|5997||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23736|31293|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23736||23736|31293||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21342|28324|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||21342||21342|28324||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|28722|37475|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||28722||28722|37475||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7054|10785|lyfalmen|V0223|7885|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7054||7054|10785||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12432|18266|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||12432||12432|18266||1 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|691108|858834|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||691108||691108|858834||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3915|7598|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3915||3915|7598||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|378|1544|lyfalmen|V0633|1544|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||340||340|1544||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|30292|57640|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||30292||30292|57640||2 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6357|9826|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6357||6357|9826||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|43671|56012|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||43671||43671|56012||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6357|9826|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6357||6357|9826||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1099|1902|lyfalmen|V0496|1902|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|980|1902|lyfalmen|V0648|1902|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1902||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1706|2866|lyfalmen|V0649|2866|2|100|0|400,0000|Medical ehf|ratiopharm GmbH|Ramipríl||1300||1300|2866||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3458|4931|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3458||3458|4931||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|15188|20693|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15188||15188|20693||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|167041|208991|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||167041||167041|208991||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|983|2080|lyfalmen|V0159|2078|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||729||729|2080||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|158099|197903|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||158099||158099|197903||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11997|17589|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11997||11997|17589||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11997|17589|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11997||11997|17589||2 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|44300|58573|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||44300|58573||1 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11997|17589|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11997||11997|17589||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11997|17589|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11997||11997|17589||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11997|17589|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11997||11997|17589||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|728818|905594|lyfsjukr|||1|6|0|8,9300|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Palifermín||728818||728818|905594||3 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|420|1654|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||420|1654||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|69480|88015|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||69480||69480|88015||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1453|2552|lyfalmen|V0160|2524|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1072||1072|2552||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|4389|5554|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||3253||3253|5554||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2812|4947|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Barnaveiki, kíghósti, mænusótt, stífkrampi||||2812|4947||1 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2711|4808|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2711||2711|4808||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|28123|38112|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||28123||28123|38112||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2298|4239|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2298||2298|4239||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|90459|114029|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||90459||90459|114029||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020305|C08DB0109|Dilmin|forðatfl|90|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|7132|4272|lyfalmen|||2|100|0|37,5000|Medical ehf|ratiopharm GmbH|Diltíazem||2322||2322|4272||2 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6328|9786|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6328||6328|9786||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|49394|65016|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||49394||49394|65016||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|5121|4676|lyfalmen|V0530|4227|1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2615||2615|4676||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|11623|5437|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3168||3168|5437||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|22290|30734|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||22290||22290|30734||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|561|1848|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||561||561|1848||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1709|3429|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1709||1709|3429||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|11741|7536|lyfalmen|V0599|7536|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||4693||4693|7536||2 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2066|3561|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2066||2066|3561||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2416|4164|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2416||2416|4164||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1871|3273|lyfalmen|V0174|2855|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1596||1596|3273||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2790|4916|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2790||2790|4916||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2193|4095|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2193||2193|4095||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1591|lyfalmen|V0188|1491|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1591||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1359|2947|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1359||1359|2947||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2150|lyfalmen|V0189|2125|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2150||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|9438|14067|lyfalmen|V0437|13369|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||9438||9438|14067||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16042|22832|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||16042||16042|22832|30.4.2015|1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|7198|10984|lyfalmen|V0436|10451|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||7198||7198|10984||3 021417|R01AD0504|Rhinocort (Lyf og heilsa)|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|15.12.2004||R|0|0|0|0|G|0|HOL|0|0|1|100|SEK|1443|3062|lyfalmen|V0443|3062|3|120|0|38,4000|Lyf og heilsa|Lyf og heilsa|Búdesóníð||1443||1443|3062||2 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1465|2089|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1465||1465|2089||2 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4071|6680|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4071||4071|6680||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12460|18301|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12460||12460|18301||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12767|18690|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12767||12767|18690||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6585|10140|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6585||6585|10140||1 021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|13992|20239|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13992||13992|20239||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|14648|20024|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||14648||14648|20024||2 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|20975|29071|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||20975||20975|29071||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|14648|20024|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||14648||14648|20024||2 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22547|31059|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22547||22547|31059||1 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3979|6553|lyfalmen|V0171|5243|1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||3979||3979|6553||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8422|12010|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||8422||8422|12010||2 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4251|6062|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4251||4251|6062||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18051||18051|25373||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|3765|6258|lyfalmen|V0692|4859|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3765||3765|6258||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|5943|9256|lyfalmen|V0693|7042|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5943||5943|9256||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|18123|25464|lyfalmen|V0694|22943|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18123||18123|25464||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|71237|90194|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||71237||71237|90194||3 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18051||18051|25373||1 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|76714|96985|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||76714||76714|96985||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|109165|137225|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||109165||109165|137225||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4484|7248|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4484||4484|7248||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|267991|334169|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||267991||267991|334169||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|281866|351374|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||281866||281866|351374||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11719|20199|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11719||11719|20199||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|21753|30055|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||21753||21753|30055||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2103|3625|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2103||2103|3625||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1202|2731|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1202||1202|2731||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1329|2291|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1329||1329|2291||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3553|2694|lyfalmen|V0056|1992|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1175||1175|2694||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6246|3642|lyfalmen|V0057|1992|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1864||1864|3642||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1992|3433|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1992||1992|3433||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|585|1882|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||585||585|1882||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1753|3489|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1753||1753|3489||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1290|2223|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1290||1290|2223||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4340|7050|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4340||4340|7050||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3102|lyfalmen|V0321|3102|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3102||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2414|lyfalmen|V0321|1861|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2414||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4625||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|27670|37539|lyfalmen|||1|8|0|40,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||27670||27670|37539||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|13835|20041|lyfalmen|||1|4|0|20,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||13835||13835|20041||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.04.2012||R|0|0|0|0|G|0|TAA|0|0|0|100|GBP|20774|28817|lyfalmen|||1|6|0|30,0000|Navamedic A/S|Aspen Pharma Trading Limited|Fondaparinux||20774||20774|28817||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2850||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2940|lyfalmen|V0124|2936|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1354||1354|2940||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|3402|lyfalmen|V0125|2603|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3402||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|74213|93884|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||74213||74213|93884||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|23862|32723|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||23862||23862|32723||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|37255|49662|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||37255||37255|49662||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2866|lyfalmen|V0125|2603|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1300||1300|2866||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|18866|26404|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||18866||18866|26404||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|5206|lyfalmen|V0125|5206|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||3000||3000|5206||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|20249|lyfalmen|V0256|20249|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||14000||14000|20249||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|11399|lyfalmen|V0254|11399|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7500||7500|11399||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|LUX|0|0|0|100|DKK|19057|26645|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||19057||19057|26645||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2403|3780|lyfalmen|V0250|3700|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1964||1964|3780||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3214|4329|lyfalmen|V0251|4239|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2363||2363|4329||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|18215|25580|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18215||18215|25580||1 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|118927|149329|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||118927||118927|149329||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|22078|26327|lyfalmen|V0029|6627|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||18805||18805|26327||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2900|5068|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2900||2900|5068||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|129335|149015|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||118673||118673|149015||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2315|lyfalmen|V0066|2270|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2315||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2522|lyfalmen|V0449|2469|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2522||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|52563|67038|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||52563||52563|67038||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2040|lyfalmen|V0448|1912|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2040||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5894|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5894||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3691|lyfalmen|V0673|3691|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1900||1900|3691||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|68967|87379|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||68967||68967|87379||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2720|4820|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2720||2720|4820||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2178|4074|lyfalmen|V0222|3758|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2178||2178|4074||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|17980|25283|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||17980||17980|25283||1 024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.09.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|14561|13464|lyfalmen|V0456|13464|2|28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||9000||9000|13464||2 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1595|2515|lyfalmen|V0048|2515|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||1045||1045|2515||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|59301|77546|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||59301||59301|77546||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2140|3642|lyfalmen|V0049|3642|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1864||1864|3642||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4308|6271|lyfalmen|V0054|6271|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3774||3774|6271||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22547|31059|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22547||22547|31059||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7098|10846|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7098||7098|10846||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|384|1605|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||384||384|1605||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7098|10846|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7098||7098|10846||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11960|17538|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11960||11960|17538||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11980|17566|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11980||11980|17566||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12102|17849|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12102||12102|17849||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5118|8121|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5118||5118|8121||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|65023|84783|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||65023||65023|84783||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12102|17849|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||12102||12102|17849||1 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1457|3082|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1457||1457|3082||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5118|8121|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||5118||5118|8121||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7098|10846|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7098||7098|10846||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7098|10846|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7098||7098|10846||1 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1457|3082|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1457||1457|3082||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2341|3141|lyfalmen|V0106|3141|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1500||1500|3141||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3193|5471|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3193||3193|5471||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4889|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4889||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3829|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3829||2 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|593|1893|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||593||593|1893||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18051||18051|25373||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2177|lyfalmen|V0051|2177|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2177||2 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18051||18051|25373||1 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|74041|93671|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||74041||74041|93671||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|69157|87615|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||69157||69157|87615||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8945|17141|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||8945||8945|17141||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|15483|22125|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||15483||15483|22125||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|4898|7818|lyfalmen|V0205|1257|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4898||4898|7818||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|13126|19144|lyfalmen|V0205|3770|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13126||13126|19144||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|49736|65448|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||49736||49736|65448||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6547|9336|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6547||6547|9336||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22547|31059|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||22547||22547|31059||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1438|2314|lyfalmen|V0597|2314|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||899||899|2314||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3674|4915|lyfalmen|V0598|4915|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||2789||2789|4915||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|48305|61758|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||48305|61758||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|41856|55481|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||41856||41856|55481||1 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12492|3972|lyfalmen|V0492|3497|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||2104||2104|3972||1 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4239|6213|lyfalmen|V0491|6125|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||3732||3732|6213||2 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3668|6322|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3668||3668|6322|30.4.2015|1 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12778|2372|lyfalmen|V0490|2288|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||941||941|2372||1 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1826|3589|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1826||1826|3589||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.07.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2205|lyfalmen|||2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíð||820||820|2205|31.3.2015|1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8675|14952|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8675||8675|14952||1 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|14152|lyfalmen|V0475|14152|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||9500||9500|14152||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18051||18051|25373||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|39814|51229|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||39814||39814|51229||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|199071|248708|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||199071||199071|248708||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1696|3411|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1696|3411||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6427|9922|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6427|9922||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3351|5689|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3351|5689||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|13272|19328|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||13272|19328||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|19889|27698|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||19889|27698||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|26506|36067|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||26506|36067||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1287|2848|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1287||1287|2848||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4765|3861|lyfalmen|V0099|3861|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Lósartan||2023||2023|3861||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|1052|2524|lyfalmen|V0160|2524|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||1052||1052|2524||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|728|2078|lyfalmen|V0159|2078|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||728||728|2078||2 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3003|lyfalmen|V0672|3003|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3003||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|383|1603|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||383||383|1603||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2617|4678|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2617||2617|4678||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6292|9737|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||6292||6292|9737||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|15541|7463|lyfalmen|V0341|7463|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4640||4640|7463||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|17841|7463|lyfalmen|V0342|7463|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4640||4640|7463||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2528|3605|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2528||2528|3605||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6500|10023|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||6500||6500|10023||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|563|1851|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||563||563|1851||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|655|1978|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||655||655|1978||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2480|lyfalmen|V0284|2153|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1020||1020|2480||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|19142|26753|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19142||19142|26753||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|22073|29231|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||22073|29231||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|22124|30524|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22124||22124|30524||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|30149|39245|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30149||30149|39245||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|44549|57101|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||44549|57101||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|4958|7901|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||4958||4958|7901||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|21201|29357|lyfalmen|V0387|29357|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||21201||21201|29357||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||2522|28.2.2015|2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|21513|29752|lyfalmen|V0386|29752|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||21513||21513|29752||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3208|4431|lyfalmen|V0364|3569|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||2437||2437|4431||2 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|47242|60440|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||47242||47242|60440||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2584|4633|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2584||2584|4633||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|42230|55955|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||42230||42230|55955||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|35074|46904|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||35074||35074|46904||2 028360|J07BG0101|Rabies - Imovax|sts|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|9211|13754|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaæði, dauð veira||9211||9211|13754||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1679|3387|lyfalmen|V0202|3387|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1679||1679|3387||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1882|3667|lyfalmen|V0428|3105|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1882||1882|3667||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2835|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2835||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|3884|lyfalmen|V0245|3483|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2040||2040|3884||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8729|lyfalmen|V0232|7799|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8729||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|746|2100|lyfalmen|V0266|2100|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||744||744|2100||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7423|14253|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7423||7423|14253||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3613|4984|lyfalmen|V0267|4984|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||2839||2839|4984||1 028739|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2272|4204|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||2272|4204||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1723|lyfalmen|V0551|1723|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||470||470|1723||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3168|lyfalmen|V0552|3168|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1520||1520|3168||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1851|lyfalmen|V0555|1851|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1851||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1875|lyfalmen|V0556|1872|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||580||580|1875||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1121|2453|lyfalmen|V0625|2347|1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1000||1000|2453||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|7086|10829|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||7086||7086|10829||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|17733|24971|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||17733||17733|24971||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2704|4798|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2704||2704|4798||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1190|2714|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1190||1190|2714||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|351|1559|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||351||351|1559||1 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|57704|73413|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||57704||57704|73413||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|18405|24682|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||18405||18405|24682||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|4004|5710|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||4004||4004|5710||1 029574|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009|28.02.2015|R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4382|6249|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4382||4382|6249||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14318|20651|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||14318|20651||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14318|20651|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||14318|20651||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|5800|9059|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5800||5800|9059||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|88925|112127|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||88925||88925|112127||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|177851|222395|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||177851||177851|222395||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|7666|11628|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7666||7666|11628||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8628|12952|lyfalmen|V0277|10498|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||8628||8628|12952||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2886|5049|lyfalmen|V0276|3463|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5049||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|15108|26040|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15108|26040||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1244|2662|lyfalmen|V0051|2177|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1152||1152|2662||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1965|3316|lyfalmen|V0106|3141|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1627||1627|3316||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2661||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2828|4969|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2828||2828|4969||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2672|4754|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2672||2672|4754||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1888|3675|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||1888||1888|3675||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5552|8718|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5552||5552|8718||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|20630|27441|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||20630||20630|27441||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1801|3555|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1801||1801|3555||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|19737|27505|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19737||19737|27505||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|13682|23582|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||13682||13682|23582||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|2109|lyfalmen|V0558|2109|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||750||750|2109||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|20004|27843|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||20004|27843||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|39898|53005|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||39898|53005||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1148|1979|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1148||1148|1979||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2883|5044|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2883||2883|5044||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8598|16483|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8598|16483||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9824|14598|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9824||9824|14598||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5769|9017|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5769||5769|9017||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|17029|24080|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17029||17029|24080||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1423|3035|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1423||1423|3035||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1883|2125|lyfalmen|V0189|2125|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||762||762|2125||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|824|1491|lyfalmen|V0188|1491|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||301||301|1491||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17612|13860|lyfalmen|V0185|13860|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||9288||9288|13860||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|87380|110211|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||87380||87380|110211||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2321|4562|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2321|4562||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1838|2396|lyfalmen|V0098|2396|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||959||959|2396||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|701|2041|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||701||701|2041||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|15923|21605|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||15923||15923|21605||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7631|11580|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7631|11580||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7631|11580|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7631|11580||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|63155|80172|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||63155||63155|80172||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1585|3258|lyfalmen|V0367|3258|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1585||1585|3258||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2652|4727|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2652||2652|4727||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|109453|137582|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||109453||109453|137582||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6987|9963|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6987||6987|9963||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2102|2997|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2102||2102|2997||2 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2337|4293|lyfalmen|||1|14|0|14,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2337|4293||1 035153|N02AB0306|Instanyl|nefúði|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9016|13486|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||9016||9016|13486||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|14977|21485|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14977||14977|21485||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1260|2811|lyfalmen|V0050|2461|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1260||1260|2811||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2001|lyfalmen|V0244|2001|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2001||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1252|2800|lyfalmen|V0048|2515|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1252||1252|2800||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2236|4154|lyfalmen|V0049|3642|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2236||2236|4154||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8708|13062|lyfalmen|V0080|5540|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8708||8708|13062||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4886|7177|lyfalmen|V0054|6271|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4432||4432|7177||2 035755|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|706|1926|lyfalmen|V0562|1621|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||617||617|1926||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|NOK|24985|31558|lyfalmen|V0680|27392|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22941||22941|31558||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|109453|137582|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||109453||109453|137582||2 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988|28.02.2015|R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|5490|8633|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||5490||5490|8633||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7294|11116|lyfalmen|V0081|4778|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7294||7294|11116||1 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006|28.02.2015|R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|193430|241713|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||193430||193430|241713||1 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006|28.02.2015|R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|351843|438145|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||351843||351843|438145||1 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006|28.02.2015|R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|703663|874402|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||703663||703663|874402||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|731|2082|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||731||731|2082||1 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|19258|26900|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||19258||19258|26900||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1284|2844|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1284||1284|2844||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4167|7182|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||4167||4167|7182||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2535|4565|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2535||2535|4565||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|769|2135|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||769||769|2135||1 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|10036|8168|lyfalmen|V0532|6106|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5152||5152|8168||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|20389|11684|lyfalmen|V0533|10308|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7707||7707|11684||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|36212|22173|lyfalmen|V0534|20452|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||15521||15521|22173||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2652|4727|lyfalmen|V0434|4727|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2652||2652|4727||2 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1765|lyfalmen|V0151|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1765||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2453|lyfalmen|V0322|2343|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2453||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3829|lyfalmen|V0323|3623|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3829||2 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2277||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3594||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7521|11428|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||7521|11428||1 038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6233|11996|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||6233||6233|11996||2 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3266|lyfalmen|V0321|3102|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3266||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|975|2418|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||975||975|2418||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|144293|180783|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||144293||144293|180783||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|15430|22058|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||15430|22058||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|30053|39126|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||30053||30053|39126||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7420|11289|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7420||7420|11289||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3815|6327|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3815|6327||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|17643|24857|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||17643|24857||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3211|5481|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3200||3200|5481||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|428|1583|lyfalmen|V0541|1440|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||368||368|1583||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|577|1627|lyfalmen|V0542|1585|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||400||400|1627||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1209|2740|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1209||1209|2740||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1742|3474|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1742||1742|3474||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1190|1697|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1190||1190|1697||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2128|lyfalmen|V0110|2085|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2128||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|8268|5417|lyfalmen|V0182|5417|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||3154||3154|5417||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2983|4254|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2983||2983|4254||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1974|2026|lyfalmen|V0033|2026|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||690||690|2026||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5950|8485|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5950||5950|8485||2 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9110|13615|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9110||9110|13615||1 040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5224|10081|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5224||5224|10081||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1224|2634|lyfalmen|V0366|2634|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1132||1132|2634||1 040475|C09DA0603|Candesartan/Hydrochlorothiazide Aspen|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3526|4947|lyfalmen|V0095|4947|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan og þvagræsilyf||2812||2812|4947||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1825||1 040620|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4435|8585|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4435||4435|8585||2 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|83618|105546|lyfsjukr|||1|5|0||Vistor hf|Ferring Lægemidler A/S|Misóprostól||||83618|105546||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1472|2855|lyfalmen|V0174|2855|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1292||1292|2855||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3285|5598|lyfalmen|V0201|5598|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Felódipín||3285||3285|5598||2 040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|||lyfalmen|||2|100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||||||| 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9765|14517|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9765||9765|14517||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|9765|14517|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||9765||9765|14517||2 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|2177|lyfalmen|V0318|2177|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||800||800|2177||2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|13091|22564|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13091||13091|22564||2 041716|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.10.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|53909|92918|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||53909||53909|92918||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3336|5750|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3336||3336|5750||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1061|2537|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1061|2537||2 041938|A02BC0508|Esomeprazol Actavis|sþ-hylki|40|mg|28|stk|1|þpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2878|2440|lyfalmen|V0005|2440|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||991||991|2440||1 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9335|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9335|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9335||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1364|2954|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1364||1364|2954||1 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7648|10906|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||7648||7648|10906||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2172|3097|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2172||2172|3097||2 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2862|4081|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2862||2862|4081||2 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1457|2078|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||1457||1457|2078||2 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2590|3693|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2590||2590|3693||2 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1285|1832|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1285||1285|1832||2 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1628|2322|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1628||1628|2322||2 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2370|4338|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||2370||2370|4338||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3065|4371|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3065||3065|4371||2 042556|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|13819|20020|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||13819||13819|20020||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1865|3665|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1865||1865|3665||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2501|4915|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2501||2501|4915||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5003|9662|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5003||5003|9662||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5752|11083|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5752||5752|11083||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2258|3220|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2258||2258|3220||2 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|4059|6663|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||4059||4059|6663||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|512|1781|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||512||512|1781||2 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2843|4054|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||2843||2843|4054||1 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|17634|5446|lyfalmen|V0516|5446|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3175||3175|5446||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4361|7079|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4361||4361|7079||1 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5102|7275|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5102||5102|7275||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|526|1800|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||526||526|1800||1 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1143|2650|lyfalmen|V0659|2650|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1143||1143|2650||1 043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 043935|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|14107|20385|lyfalmen|V0637|20385|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||14107||14107|20385||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|355386|442539|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||355386|442539||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|451451|561659|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||451451|561659||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5514|8666|lyfalmen|V0156|8666|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5514||5514|8666||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|15982|22756|lyfalmen|V0635|20502|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||15982||15982|22756||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|46621|61508|lyfalmen|V0636|43016|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||46621||46621|61508||1 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2497|4513|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2497||2497|4513||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dæla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|1945|3823|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||1945||1945|3823||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045385|J07BF0301|Imovax Polio|stl|||0,5|ml|10|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|6908|10584|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||6908||6908|10584||2 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1795|lyfalmen|V0109|1759|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1795||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1665|lyfalmen|V0108|1632|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1665||1 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|387|1609|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||387||387|1609||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1960|3774|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1960||1960|3774||1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19724|37591|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19724||19724|37591||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1468|3097|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1468||1468|3097||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|961|2032|lyfalmen|V0648|1902|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||694||694|2032||1 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|3667|6124|lyfalmen|V0382|6124|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3667||3667|6124||2 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|633|1846|lyfalmen|V0021|1755|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||559||559|1846||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|749|2107|lyfalmen|V0022|2103|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||749||749|2107||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|959|2396|lyfalmen|V0023|2387|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||959||959|2396||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|6107|9482|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6107||6107|9482||2 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2934|lyfalmen|V0625|2934|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||1350||1350|2934||2 046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|GBP|5399|4227|lyfalmen|V0530|4227|2|84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||2289||2289|4227||2 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.09.2011|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|||lyfalmen|||2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||||||| 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3770|lyfalmen|V0205|3770|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3770||1 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|3141|lyfalmen|V0279|3141|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1500||1500|3141||1 046845|N06AB0605|Sertraline Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|2240|2343|lyfalmen|V0322|2343|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Sertralín||920||920|2343||1 046867|N06AB0605|Sertraline Portfarma|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|4495|3623|lyfalmen|V0323|3623|2|100|0|200,0000|Portfarma ehf|Portfarma ehf|Sertralín||1850||1850|3623||1 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|909|2327|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||909||909|2327||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18461|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18461||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|60828|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|60828||5 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|11791|7804|lyfalmen|V0420|4029|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíð||4888||4888|7804||1 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|14159|8067|lyfalmen|V0421|8067|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíð||5079||5079|8067||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4597|6555|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||4597||4597|6555||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8149|11620|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8149||8149|11620||2 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7458|10635|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||7458||7458|10635||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2526|3336|lyfalmen|V0324|3336|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1642||1642|3336||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2346|4305|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2346||2346|4305||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7282|3537|lyfalmen|V0325|3537|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1788||1788|3537||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7154|4936|lyfalmen|V0326|4936|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2804||2804|4936||1 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3669|6126|lyfalmen|||2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3669||3669|6126||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14305|5935|lyfalmen|V0327|5935|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3530||3530|5935||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1118|2615|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||1118||1118|2615||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12974|18952|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||12974||12974|18952||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1674|3380|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1674||1674|3380||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|57530|72117|lyfalmen|V0187|13737|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||55009||55009|72117||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|816713|1014584|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||816713||816713|1014584||1 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|449|1694|lyfalmen|V0230|1612|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||449||449|1694||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|4030|5747|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||4030||4030|5747||1 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2287|4224|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2287||2287|4224||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4471|4947|lyfalmen|V0599|4522|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||2812||2812|4947||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5804|9065|lyfalmen|V0376|4905|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5804|9065||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|15538|22194|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||15538||15538|22194||2 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2237|4155|lyfalmen|V0122|4155|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2237||2237|4155||1 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5497|8642|lyfalmen|V0663|8642|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5497||5497|8642||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|7201|10988|lyfalmen|V0655|4655|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||7201||7201|10988||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1971|lyfalmen|V0109|1759|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1971||1 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2418|lyfalmen|V0110|2128|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||975||975|2418||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|7644|4938|lyfalmen|V0123|3884|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2806||2806|4938||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1118|2109|lyfalmen|V0496|1902|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||750||750|2109||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2304|3146|lyfalmen|V0649|2866|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1504||1504|3146||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1419||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1517||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|76003|98671|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||76003||76003|98671||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|139305|174598|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||139305||139305|174598||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|57530|75306|lyfalmen|V0470|71625|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||57530||57530|75306||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|7499|10694|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||7499||7499|10694||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|18748|25108|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||18748||18748|25108||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|34827|45045|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||34827||34827|45045||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|69653|88230|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||69653||69653|88230||2 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3083|5320|lyfalmen|V0445|4703|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríð||3083||3083|5320||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0150|2575|0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2575||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4016|6604|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||4016||4016|6604||2 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|1|0|100|DKK|536297|666868|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||536297||536297|666868||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29735|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29735||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|65526|83112|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||65526|83112||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2944|5128|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2944||2944|5128||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12417|18247|lyfalmen|V0688|17180|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12417||12417|18247||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5137|5003|lyfalmen|V0042|4614|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2853||2853|5003||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5371|lyfalmen|V0002|5371|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5371||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3554|lyfalmen|V0006|3554|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1800||1800|3554||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|10567|4415|lyfalmen|V0001|3084|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2426||2426|4415||1 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1593|3269|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1593||1593|3269||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1622|3309|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1622||1622|3309||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1273|2263|lyfalmen|V0363|2263|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||862||862|2263||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3462|4502|lyfalmen|V0365|4502|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2489||2489|4502||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|20510|27292|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||20510||20510|27292||1 051686|N05AE0402|Zeldox (Lyf og heilsa)|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|25297|25377|lyfalmen|V0611|25377|3|56|0|56,0000|Lyf og heilsa|Lyf og heilsa|Ziprasidon||18054||18054|25377||2 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1473|2001|lyfalmen|V0056|1992|2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||672||672|2001||2 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2474|2435|lyfalmen|V0057|1992|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||987||987|2435||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|824|2210|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||824||824|2210||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|191|1339|lyfalmen|V0047|1339|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||191||191|1339||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|450|1696|lyfalmen|V0305|990|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||450||450|1696||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|285781|356228|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||285781||285781|356228||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|319|1500|lyfalmen|V0439|1500|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||308||308|1500||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|786|2136|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||770||770|2136||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|656|1979|lyfalmen|V0305|1979|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||656||656|1979||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|577498|717958|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||577498||577498|717958||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|541441|673247|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||541441||541441|673247||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3369|5713|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3369||3369|5713||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|33009|42791|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||33009||33009|42791||2 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26836|35137|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||26836||26836|35137||2 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|27291|35701|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||27291||27291|35701||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23930|31533|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||23930||23930|31533||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0682|28574|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|14001|20250|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíð||14001||14001|20250||1 052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|434|1521|lyfalmen|V0060|1518|2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||323||323|1521||2 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2127|3665|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||1881||1881|3665||2 053025|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2045|3891|lyfalmen|V0134|3086|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2045||2045|3891||2 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4613|7426|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4613||4613|7426||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11333|16675|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11333||11333|16675||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|33755|45235|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||33755||33755|45235||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5651|8854|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5651||5651|8854||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1657|3350|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1652||1652|3350||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6581|10134|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6581||6581|10134||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|32555|43718|lyfalmen|V0453|41180|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||32555||32555|43718||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|16815|23810|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16815||16815|23810||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1449|3071|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1449||1449|3071||1 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1081|2564|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1081||1081|2564||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7333|2500|lyfalmen|V0490|2335|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||1034||1034|2500||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3937|6495|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||3937||3937|6495||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2554|4592|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2554||2554|4592||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3523|5925|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3523||3523|5925||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|39756|51157|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||39756||39756|51157||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1408|3014|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1408||1408|3014||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|977|2421|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||977||977|2421||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1596|3273|lyfalmen|V0061|3273|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1596||1596|3273||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|SOG|1|0|0|100|DKK|4494|8697|vetalmen|||0|10|0||Icepharma hf|Sogeval UK Limited|Buprenorphinhýdróklóríð||||4494|8697||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7278|12544|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7278||7278|12544||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|SEK|5188|8217|lyfalmen|||1|60|0|30,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíð||5188||5188|8217||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|19201|23875|lyfalmen|V0470|23875|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||16867||16867|23875||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|18831|4579|lyfalmen|V0187|4579|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2545||2545|4579||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1968|3785|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1968|3785||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|697|2036|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||697||697|2036||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1258|2556|lyfalmen|V0065|1915|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||1075||1075|2556||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|8719|13077|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8719||8719|13077||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|2064|2453|lyfalmen|V0467|2453|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4539|3058|lyfalmen|V0112|2728|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1440||1440|3058||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6185|3726|lyfalmen|V0113|3485|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|7867|3726|lyfalmen|V0114|3485|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1925||1925|3726||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|30409|41003|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||30409||30409|41003||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|25581|44091|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||25581||25581|44091||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1135|2639|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1135||1135|2639||1 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3527|3499|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1760||1760|3499||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3527|3499|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1760||1760|3499||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2639|4709|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2639||2639|4709||1 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|203960|254770|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||203960||203960|254770||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9694|14419|lyfalmen|V0095|4848|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||9694||9694|14419||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|7139|10180|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||7139||7139|10180||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3562|5079|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3562||3562|5079||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|3569|5089|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3569||3569|5089||1 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|20827|28884|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20827||20827|28884||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4624|6594|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||4624||4624|6594||2 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|2514|3585|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2514||2514|3585||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|324991|404849|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||324991||324991|404849||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|431747|537226|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||431747||431747|537226||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|22055|12891|lyfalmen|V0607|12871|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||8584||8584|12891||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|19073|26666|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19073|26666||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|403|1631|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||403||403|1631||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|1|0|100|GBP|138733|173889|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||138733||138733|173889||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|153690|264900|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||153690|264900||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|233470|402409|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||233470|402409||2 058300|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9485|14131|lyfalmen|V0587|14130|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9485||9485|14131||1 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|918|2340|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||918||918|2340||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|89987|113444|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||89987||89987|113444||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|37267|49677|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||37267||37267|49677||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5235|7465|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5235||5235|7465||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1042|2511|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1042||1042|2511||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1943|3751|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1943||1943|3751||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2848|lyfalmen|V0006|1990|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2848||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|11183|16469|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11183||11183|16469||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|93857|121252|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||93857||93857|121252||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|35544|47498|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||35544||35544|47498||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|36396|42572|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||31649||31649|42572||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|3485|lyfalmen|V0114|3485|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3485||2 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5354|8446|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5354|8446||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8474|12740|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8474||8474|12740||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|42373|56135|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||42373||42373|56135||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2572|3356|lyfalmen|V0219|3356|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1656||1656|3356||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4084|5651|lyfalmen|V0220|5651|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3324||3324|5651||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5295|7263|lyfalmen|V0221|7263|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4495||4495|7263||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6174|7885|lyfalmen|V0223|7885|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4947||4947|7885||2 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|321689|409414|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||321689||321689|409414||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|178143|227857|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||178143||178143|227857||1 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|NOK|144224|180698|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||144224|180698||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|100231|126146|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||100231||100231|126146||2 061414|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2598|5099|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2598|5099||2 061442|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1361|2675|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1361|2675||2 061451|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8040|15424|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8040|15424||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|6603|10165|lyfalmen|V0133|7773|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||6603||6603|10165||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|6604|10166|lyfalmen|V0133|7773|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||6604||6604|10166||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1609|2773|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1609||1609|2773||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3918|5587|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3918||3918|5587||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|14985|20441|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||14985||14985|20441||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|20854|27719|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||20854||20854|27719||1 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|434|1674|lyfalmen|V0307|1542|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||434||434|1674||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6330|4077|lyfalmen|V0604|3182|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2180||2180|4077||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|15272|14211|lyfalmen|V0187|13737|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9543||9543|14211||1 062387|N04BC0502|Sifrol|forðatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1559|3222|lyfalmen|V0634|1689|1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1559||1559|3222||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|53909|92918|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||53909||53909|92918||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|875|2281|lyfalmen|V0308|2015|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||875||875|2281||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1901|3693|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1901||1901|3693||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|17017|29331|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||17017||17017|29331||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|15743|17564|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||11979||11979|17564||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|157433|201663|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||157433||157433|201663||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|3979|6553|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||3979||3979|6553||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1734|3463|lyfalmen|V0276|3463|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1734||1734|3463||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|6845|10498|lyfalmen|V0277|10498|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||6845||6845|10498||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2948||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2403|3939|lyfalmen|V0123|3884|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2080||2080|3939||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3938|6091|lyfalmen|V0458|4085|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3643||3643|6091||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7353|10485|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7353||7353|10485||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2401|4138|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2401||2401|4138||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|138722|173875|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||138722||138722|173875||2 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|919|2341|lyfalmen|V0309|1949|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||919||919|2341||1 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1926|3727|lyfalmen|V0310|2907|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1926||1926|3727||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|81893|103407|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||81893|103407||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|125285|157213|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||125285|157213||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|887980|1102955|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||887980|1102955||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|411087|511608|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||411087|511608||2 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2022|3859|lyfalmen|V0311|2907|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2022||2022|3859||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4110876|5099346|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4110876|5099346||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1614509|2003851|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1614509|2003851||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3281|3660|lyfalmen|V0009|3457|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1877||1877|3660||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|7784|6627|lyfalmen|V0029|6627|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||4033||4033|6627||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1118|2197|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1118||1118|2197||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1985|3808|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1985||1985|3808||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|988|2098|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||742||742|2098||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|46572|59609|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||46572||46572|59609||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|TAS|0|0|1|100|DKK|785|2157|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda Nycomed AS|Metóklópramíð||785||785|2157||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|17109|21339|lyfalmen|V0441|21339|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||14862||14862|21339||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|451|1697|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíð||451||451|1697||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1845|3616|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1845||1845|3616||1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5558|10715|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5558||5558|10715||2 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|11489|16106|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||11489||11489|16106||2 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999|28.02.2015|R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2481|3814|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1989||1989|3814||1 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|52366|64696|lyfalmen|V0451|64696|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||49141||49141|64696||3 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009|28.02.2015|R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6087|9454|lyfalmen|||1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||6087||6087|9454||1 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|954|1968|lyfalmen|V0163|1968|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|1968||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3630|5176|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3630||3630|5176||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|566|1855|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||566||566|1855||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1708|3427|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1708||1708|3427||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3176|5448|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3176||3176|5448||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4245|8224|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4245||4245|8224||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5905|9204|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||5905||5905|9204||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29325|38223|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||29325||29325|38223||2 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|801|2179|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||801||801|2179||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3829|lyfalmen|V0006|3554|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2000||2000|3829||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|1000|2453|lyfalmen|V0036|2453|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||1000||1000|2453||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3695|5269|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3695||3695|5269||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8161|11638|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8161||8161|11638||2 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010|28.02.2015|R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1013|2471|lyfalmen|||2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1013||1013|2471||1 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998|31.03.2015|R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1851|lyfalmen|V0555||2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1851||1 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|12776|lyfalmen|V0419|12776|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12776||1 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|112121|140890|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||112121||112121|140890||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|1|0|100|GBP|79752|100752|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||79752||79752|100752||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1595|3272|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1595||1595|3272||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|5021|7987|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||5021||5021|7987||1 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.04.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|17484|10115|lyfalmen|V0342|7314|2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||6567||6567|10115||2 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3235|5529|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3235||3235|5529||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2381|3395|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríð||2381||2381|3395||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2225|3173|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríð||2225||2225|3173||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13370|19452|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||13370||13370|19452||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|42202|55919|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||42202||42202|55919||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380669|473890|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380669||380669|473890||2 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010|31.03.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|15525|22178|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||15525|22178||1 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010|31.03.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22388|30858|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||22388|30858||1 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010|31.03.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|28811|38982|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||28811|38982||1 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8646|12977|lyfalmen|V0589|12977|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||8646||8646|12977||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|11178|16462|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||11178||11178|16462||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|58635|74567|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||58635||58635|74567||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|296545|369576|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||296545||296545|369576||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1951|1749|lyfalmen|V0247|1749|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||489||489|1749||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3010|3364|lyfalmen|V0248|3364|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1662||1662|3364||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5906|3769|lyfalmen|V0249|3769|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1956||1956|3769||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12723|17553|lyfalmen|V0252|17553|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||11971||11971|17553||2 071591|N05AH0405|Seroquel Prolong|forðatfl|150|mg|30|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|7710|11688|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||7710|11688||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10292|4912|lyfalmen|V0144|4912|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2787||2787|4912||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|78243|98881|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||78243||78243|98881||1 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|2984|3704|lyfalmen|V0009|3704|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1909||1909|3704||1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6633|12755|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6633||6633|12755||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|7785|6627|lyfalmen|V0029|6627|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4033||4033|6627||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|179771|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|179771||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|179771|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|179771||5 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|556|793|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||556||556|793||1 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|15638|22321|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||15638||15638|22321||1 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|15638|22321|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||15638||15638|22321||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|58604|74529|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||58604||58604|74529||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8396|8583|lyfalmen|V0286|6382|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||5454||5454|8583||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|365208|454718|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||365208|454718||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|635257|789579|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||635257||635257|789579||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4064|6670|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð og tamsúlósínhýdroklóríð||4064||4064|6670||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|17612|13860|lyfalmen|V0185|13860|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||9288||9288|13860||1 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|288|1473|lyfalmen|V0047|1339|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||288||288|1473||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|905|2322|lyfalmen|V0305|1979|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||905||905|2322||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|487|1747|lyfalmen|V0439|1500|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||487||487|1747||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1323|2897|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1323||1323|2897||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|3112|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1479||1479|3112||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3523|6072|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3523||3523|6072||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1445|3065|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||1445||1445|3065||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3389|5741|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3389||3389|5741||1 074083|B03BB0106|Folic Acid (Lyf og heilsa)|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.03.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|GBP|435|1675|lyfalmen|V0391|1675|3|28|0|350,0000|Lyf og heilsa|Lyf og heilsa|Fólínsýra||435||435|1675||2 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0666|30351|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|670|1999|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||670||670|1999||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|626|1938|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||626||626|1938||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|976|2420|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||976||976|2420||1 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|21259|36642|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||21259||21259|36642||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|442|1685|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||442||442|1685||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|765|2129|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||765||765|2129||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|1030|2494|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||1030||1030|2494||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|549|1832|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||549||549|1832||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|2540|4572|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||2540||2540|4572||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4615|7428|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4615||4615|7428||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13844|20052|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13844||13844|20052||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4615|7428|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4615||4615|7428||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1564|2578|lyfalmen|V0363|2263|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1091||1091|2578||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|13844|20052|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13844||13844|20052||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|IKR|3144|5404|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5404||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|IKR|4555|7346|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||4555||4555|7346||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2463|4466|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun||||2463|4466||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3882|4703|lyfalmen|V0445|4703|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríð||2635||2635|4703||1 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|25927|34009|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||25927||25927|34009||1 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|70683|89507|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||70683||70683|89507||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|996|1958|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||996||996|1958||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|12093|17837|lyfalmen|V0440|17837|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||12093||12093|17837||2 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5266|7509|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5266||5266|7509||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5266|7509|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5266||5266|7509||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5734|8177|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5734||5734|8177||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|548|1831|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||548||548|1831||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|601|1904|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||601||601|1904||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6185|9589|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6185||6185|9589||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|20630|28635|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||20630|28635||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21547|29795|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||21547||21547|29795||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21559|29810|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||21559||21559|29810||1 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1689|lyfalmen|V0045|1689|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1689||1 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|2384|lyfalmen|V0290|2384|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||950||950|2384||1 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|2315|lyfalmen|V0291|2315|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||900||900|2315||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1568|3235|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1568||1568|3235||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2453|lyfalmen|V0290|2384|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1000||1000|2453||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|254801|317813|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||254801||254801|317813||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|169868|212496|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||169868||169868|212496||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|85064|107339|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||85064||85064|107339||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|42782|54910|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||42782||42782|54910||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|448|1693|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||448||448|1693||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|QUI|0|0|0|100|XEU|50485|64461|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin|Storkuþættir lX,ll,Vll,X||50485||50485|64461||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|367|1581|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1581||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1042|2511|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2511||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|872|2277|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||872||872|2277||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1025|2384|lyfalmen|V0671|2384|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||950||950|2384||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|1700|3416|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||1700||1700|3416||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3300|5618|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5618||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|5000|7958|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|7958||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|6300|9748|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9748||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|8120|12253|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12253||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|851|2248|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||851||851|2248||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12776|lyfalmen|V0419|11924|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12776||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|474|1729|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||474||474|1729||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|721|2069|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||721||721|2069||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1318|2890|lyfalmen|V0560|2890|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1318||1318|2890||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1884|3669|lyfalmen|V0561|3669|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1884||1884|3669||2 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002|31.03.2015|R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|120861|151728|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||120861||120861|151728||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8387|5921|lyfalmen|V0069|2943|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3520||3520|5921||1 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3437|5807|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3437||3437|5807||2 079269|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17363|24503|lyfalmen|V0639|24503|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17363||17363|24503||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3605|6038|lyfalmen|V0315|6038|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3605||3605|6038||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6031|lyfalmen|V0184|5370|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6031||2 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1949|2779|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1949||1949|2779||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1617||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1954||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1967||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2684||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3783|7348|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3783|7348||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|6307|lyfalmen|V0020|2368|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||3800||3800|6307||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14159|10353|lyfalmen|V0421|8067|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||6740||6740|10353||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10244|17657|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10244||10244|17657||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|15636|6458|lyfalmen|V0170|6458|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||3910||3910|6458||2 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|17612|13860|lyfalmen|V0185|13860|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||9288||9288|13860||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2115|3987|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2115||2115|3987||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6389|9870|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6389||6389|9870||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2502|2204|lyfalmen|V0143|1467|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||819||819|2204||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3318|5643|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3318||3318|5643||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7071|4524|lyfalmen|V0143|4402|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2505||2505|4524||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2762|2377|lyfalmen|V0144|1637|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||945||945|2377||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|14073|19311|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14073||14073|19311||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10293|5188|lyfalmen|V0144|4912|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2987||2987|5188||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|27743|36261|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||27743||27743|36261||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|690496|858075|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||690496||690496|858075||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7578|4082|lyfalmen|V0515|4082|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2184||2184|4082||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4336|7044|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4336||4336|7044||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1715|3437|lyfalmen|V0590|3082|2|84|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel||1715||1715|3437||2 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1659|2366|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1659||1659|2366||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4875|7786|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4875||4875|7786||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|6865|10525|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6865||6865|10525||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16075|8838|lyfalmen|V0184|5263|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5639||5639|8838||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|28925|37727|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||28925||28925|37727||2 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8124|14003|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8124||8124|14003||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|37399|64461|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||37399||37399|64461||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|799|2176|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||799||799|2176||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|697|2021|lyfalmen|V0229|2021|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||686||686|2021||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3196|5475|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3196||3196|5475||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5656|8861|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5656||5656|8861||1 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3522|5924|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3522||3522|5924||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3834|6353|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3834||3834|6353||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8464|5653|lyfalmen|V0080|5653|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3325||3325|5653||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12326|18132|lyfalmen|V0354|16626|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12326||12326|18132||1 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|16846|23849|lyfalmen|V0186|23849|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||16846||16846|23849||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12873|18824|lyfalmen|V0344|15681|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12873||12873|18824||1 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5204|8239|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5204||5204|8239||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5811|11195|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5811||5811|11195||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|27934|37873|lyfalmen|V0346|33490|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||27934||27934|37873||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1228|2767|lyfalmen|V0231|2549|1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1228||1228|2767||1 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|252|1423|lyfalmen|V0642|1423|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||252||252|1423||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1910|2907|lyfalmen|V0311|2907|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1330||1330|2907||2 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|486|1745|lyfalmen|V0643|1745|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||486||486|1745||1 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64489|81826|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64489||64489|81826||1 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|54404|69321|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||54404||54404|69321||2 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|70924|89806|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||70924||70924|89806||2 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|88656|111793|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||88656||88656|111793||2 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|18136|24349|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||18136||18136|24349||2 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|27203|35592|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||27203||27203|35592||2 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|36269|46834|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||36269||36269|46834||2 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|11065|15581|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||11065|15581||2 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|43995|56414|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||43995|56414||2 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|121460|152470|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||121460|152470||2 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|235880|294351|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||235880||235880|294351||1 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|840|2232|lyfalmen|V0660|2232|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||840||840|2232||1 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9963|14789|lyfalmen|V0661|14789|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||9963||9963|14789||1 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|32422|43549|lyfalmen|V0662|43549|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||32422||32422|43549||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|40934|52618|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||40934||40934|52618||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|11924|17489|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11924||11924|17489||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|36189|48314|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||36189||36189|48314||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2462|4465|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2462||2462|4465||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|27934|37873|lyfalmen|V0345|33490|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||27934||27934|37873||1 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2117|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2117||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4827|6883|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4827||4827|6883||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16796|23786|lyfalmen|V0412|21675|1|375|0|12,5000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||16796|23786||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|32264|43350|lyfalmen|V0412|43350|1|750|0|25,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||32264|43350||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|16284|22035|lyfalmen|V0652|22035|1|100|0|100,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||15412||15412|22035||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|85258|107580|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||85258||85258|107580||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|AGP|0|0|0|100|SEK|19334|26996|lyfalmen|V0579|26996|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||19334||19334|26996||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|37319|49743|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||37319||37319|49743||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3990|5690|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3990||3990|5690||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|2627|4692|lyfalmen|V0465|3921|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2627||2627|4692||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|7765|11764|lyfalmen|V0465|11764|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||7765||7765|11764||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|387|1609|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||387||387|1609||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1811|3569|lyfalmen|V0364|3569|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1811||1811|3569||1 086018|N02CC0404|Rizatriptan Actavis|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3547|1857|lyfalmen|V0621|1757|2|6|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Rizatriptan||567||567|1857||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|4604|5270|lyfalmen|V0365|4502|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3047||3047|5270||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|60818|79465|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||60818||60818|79465||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0666|30351|1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8860|12634|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8860||8860|12634||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9617|13714|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9617||9617|13714||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13036|19030|lyfalmen|V0012|5272|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13036||13036|19030||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|27553|37391|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||27553|37391||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|55270|72447|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||55270|72447||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|48712|62263|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||48712||48712|62263||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|17037|24090|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) með prógestógen||||17037|24090||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|46724|59798|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||46724||46724|59798||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|359|1570|lyfalmen|V0060|1518|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||359||359|1570||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|115602|145206|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||115602||115602|145206||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|243|1411|lyfalmen|V0312|402|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||243||243|1411||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|214|1371|lyfalmen|V0312|1207|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||214||214|1371||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1802|3557|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1802||1802|3557||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|46713|18597|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12694||12694|18597||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|46713|18597|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12694||12694|18597||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3700||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2447|4444|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2447||2447|4444||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|782|2153|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||782||782|2153||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3281|3530|lyfalmen|V0009|3457|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1783||1783|3530||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|29489|50827|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||29489||29489|50827||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3544|6894|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3544||3544|6894||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|24983|43061|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24983||24983|43061||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|3095|5336|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3095||3095|5336||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1343|2925|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1343||1343|2925||1 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1362|2951|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1362||1362|2951||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|5257|8312|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5257||5257|8312||1 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20454|28412|lyfalmen|V0684|28412|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||20454||20454|28412||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8995|13457|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||8995||8995|13457||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12165|7463|lyfalmen|V0342|7314|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4640||4640|7463||2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4737|7596|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4737||4737|7596||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|9151|13672|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9151||9151|13672||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|14040|20300|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14040||14040|20300||1 088737|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.06.2014||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|5395|7693|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||5395||5395|7693||1 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14159|10399|lyfalmen|V0421|8067|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||6773||6773|10399||1 088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|17436|33250|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||17436||17436|33250||2 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2782|4905|lyfalmen|V0376|4905|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||2782||2782|4905||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1381|2977|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1381||1381|2977||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|21952|30307|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||21952||21952|30307||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5800||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|115602|145206|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||115602||115602|145206||1 089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3572|5993|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3572||3572|5993||2 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|20402|27158|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||20402||20402|27158||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|48966|62578|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||48966||48966|62578||1 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2041|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2041||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|23147|31818|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||23147||23147|31818||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|92586|119645|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||92586||92586|119645||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1959|3773|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1959||1959|3773||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3920|6472|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3920||3920|6472||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|886|2296|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||886||886|2296||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5428|7740|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5428||5428|7740||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|121655|156411|lyfalmen|V0140|156411|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||121655||121655|156411||3 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1483|3118|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1483||1483|3118||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|840|2232|lyfalmen|V0660|2232|1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||840||840|2232||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|17139|23112|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||17139|23112||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2440|3479|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2440||2440|3479||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4222|6021|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4222||4222|6021||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|12393|17227|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||12393||12393|17227||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|3696|6163|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3696||3696|6163||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6123|9504|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6123||6123|9504||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1116|1591|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1116||1116|1591||1 091638|J01CR0501|Piperacillin/Tazobactam Actavis|irs|4,5|g|1|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.11.2014|30.04.2015|R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1425|2032|lyfsjukr|||2|1|0|0,2800|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1425||1425|2032||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|6871|9798|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6871|9798||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3701|6170|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3701||3701|6170||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1050|1755|lyfalmen|V0021|1755|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||493||493|1755||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1816|2103|lyfalmen|V0022|2103|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||746||746|2103||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|584|1880|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||584||584|1880||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8544|16380|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8544||8544|16380||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|6603|9293|lyfalmen|V0009|3457|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||5970||5970|9293||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|10949|5558|lyfalmen|V0606|5123|2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||3256||3256|5558||2 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2117|3990|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2117||2117|3990||1 092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|8627|12951|lyfalmen|V0277|10498|3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||8627||8627|12951||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|614|1921|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||614||614|1921||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|1166|2681|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1166||1166|2681||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|3131|2790|lyfalmen|V0203|2790|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1245||1245|2790||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6444|lyfalmen|V0107|6444|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3900||3900|6444||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|929|2355|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||929||929|2355||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2132|4011|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2132||2132|4011||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|4145|6781|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||4145||4145|6781||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6762|10384|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6762||6762|10384||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5724|8955|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5724||5724|8955||1 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1366|2956|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1366||1366|2956||1 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|24625|42444|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||24625||24625|42444||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2370|4338|lyfalmen|V0656|4338|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2370||2370|4338||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|34852|46623|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||34852||34852|46623||2 093736|L02AE0305|Zoladex LA (Lyf og heilsa)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|G|0|HOL|0|0|0|100|SEK|53037|65630|lyfalmen|||3|1|0|83,7209|Lyf og heilsa|Lyf og heilsa|Góserelín||49880||49880|65630|30.4.2015|2 093747|C09AA0503|Ramipril Actavis (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|XEU|750|2109|lyfalmen|V0496|1902|3|100|0|200,0000|Lyf og heilsa|Lyf og heilsa|Ramipríl||750||750|2109||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|8911|13341|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||8911||8911|13341||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|23097|31755|lyfalmen|V0588|21484|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||23097||23097|31755||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|369772|460377|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||369772||369772|460377||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|417456|519505|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||417456||417456|519505||1 094099|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|þpakki||N02CC05|01.06.2013|28.02.2015|R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|2296|4237|lyfalmen|||1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2296||2296|4237||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4546|7333|lyfalmen|V0236|6899|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4546||4546|7333||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|6737|10349|lyfalmen|V0236|10349|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||6737||6737|10349||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1659|3261|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1659||1659|3261||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|987|2293|lyfalmen|V0044|2293|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||884||884|2293||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|28932|20452|lyfalmen|V0534|20452|2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||14160||14160|20452||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|86370|108959|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||86370||86370|108959||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|44210|58459|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||44210|58459||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6032|10397|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6032||6032|10397||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|37588|48469|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||37588||37588|48469||1 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3247|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|Magnesíum hýdroxíð||1577||1577|3247||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|4713|3182|lyfalmen|V0143|2935|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1530||1530|3182||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6862|10521|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6862||6862|10521||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15890|22640|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15890||15890|22640||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15890|22640|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15890||15890|22640||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1790|2553|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1790||1790|2553||1 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2803|3997|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2803||2803|3997||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|15890|22640|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15890||15890|22640||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2080|2966|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2080|2966||1 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3251|4636|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3251|4636||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|931|1540|lyfalmen|V0225|1540|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||337||337|1540||1 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990|30.04.2015|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|29296|38187|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||29296||29296|38187||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|88445|111532|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||88445||88445|111532||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2234|2381|lyfalmen|V0088|2357|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||948||948|2381||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2326|2678|lyfalmen|V0089|2656|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||1164||1164|2678||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2175|4070|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2175||2175|4070||1 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14027|20283|lyfalmen|V0347|17731|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14027||14027|20283||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|639736|795133|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||639736||639736|795133||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|678155|842772|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||678155||678155|842772||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|683006|848787|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||683006||683006|848787||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|744546|925097|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||744546||744546|925097||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14964|21468|lyfalmen|V0349|19096|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14964||14964|21468||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1380|2976|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1380||1380|2976||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|15433|22062|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||15433||15433|22062||1 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25123|33013|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||25123||25123|33013||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|68236|117612|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||68236||68236|117612||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7536|14468|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7536|14468||2 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2025|3864|lyfalmen|V0461|3864|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2025||2025|3864||2 097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|536|1814|lyfalmen|V0333|785|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||536||536|1814||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10320|15281|lyfalmen|V0334|3014|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10320||10320|15281||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|19593|27323|lyfalmen|V0335|3014|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||19593|27323||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2254|4179|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráð lyf|Lórazepam||2254||2254|4179||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5752|11083|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5752||5752|11083||2 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2606|2387|lyfalmen|V0023|2387|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||952||952|2387||1 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2239|lyfalmen|V0233|2190|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||845||845|2239||1 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1948|lyfalmen|V0234|1910|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||633||633|1948||1 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1023|2153|lyfalmen|V0329|1765|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||782||782|2153||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4271|3722|lyfalmen|V0678|3416|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1922||1922|3722||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|5735|3722|lyfalmen|V0679|3691|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1922||1922|3722||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5296|10218|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5296||5296|10218||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|607|1912|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||607||607|1912||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|607|1912|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||607||607|1912||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1627|lyfalmen|V0243|1627|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1627||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1902|lyfalmen|V0244|1787|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1902||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3554|lyfalmen|V0245|3554|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3554||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|7958|lyfalmen|V0232|7958|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|7958||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5530|7886|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||5530||5530|7886||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|15435|22064|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||15435||15435|22064||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|70780|89627|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||70780||70780|89627||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2918|2407|lyfalmen|V0284|2153|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||967||967|2407||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6082|4754|lyfalmen|V0285|4369|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2672||2672|4754||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|9454|9786|lyfalmen|V0286|6382|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||6328||6328|9786||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2734|2005|lyfalmen|V0247|1749|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||675||675|2005||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3780|3861|lyfalmen|V0248|3364|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2023||2023|3861||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7679|4392|lyfalmen|V0249|3769|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2409||2409|4392||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|162444|203291|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||162444||162444|203291||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|313109|390115|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||313109||313109|390115||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|626196|778343|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||626196||626196|778343||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|752|2111|lyfalmen|V0414|2111|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||752||752|2111||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|6370|10268|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||6370||6370|10268||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10948|16145|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10948|16145||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1870|3368|lyfalmen|V0672|3003|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1665||1665|3368||1 100482|J01DH0202|Merinfec|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.08.2013|31.03.2015|R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|9937|14170|lyfsjukr|||2|5000|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||9937|14170||1 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2180|4077|lyfalmen|V0685|4077|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2180||2180|4077||2 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10647|12589|lyfalmen|V0254|11399|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8364||8364|12589||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16110|22918|lyfalmen|V0256|20249|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16110||16110|22918||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|67732|109184|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||67732||67732|109184||1 101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|5863|3054|lyfalmen|V0604|2970|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||1437||1437|3054||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1261|2166|lyfalmen|V0330|1765|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||792||792|2166||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2591|2996|lyfalmen|V0331|2590|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1395||1395|2996||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2749|2405|lyfalmen|V0088|2405|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||965||965|2405||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3775|2710|lyfalmen|V0089|2710|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1187||1187|2710||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|11560|22102|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||11560||11560|22102||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|6595|10154|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6595||6595|10154||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|19782|27562|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||19782||19782|27562||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|995|2446|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||995||995|2446||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1550|3210|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1550||1550|3210||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5950|8485|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5950||5950|8485||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|389|1612|lyfalmen|V0230|1612|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||389||389|1612||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|6748|10364|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||6748||6748|10364||1 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3311|5634|lyfalmen|V0041|2671|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3311||3311|5634||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|14862|21339|lyfalmen|V0441|21339|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||14862||14862|21339||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1518|lyfalmen|V0060|1518|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||321||321|1518||2 103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|813|1159|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||813||813|1159||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2997|2739|lyfalmen|V0088|2357|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||1208||1208|2739||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4280|3325|lyfalmen|V0089|2656|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||1634||1634|3325||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2992|3513|lyfalmen|V0069|2943|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1770||1770|3513||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|2716|2026|lyfalmen|V0033|2026|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||690||690|2026||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|7828|5211|lyfalmen|V0182|5159|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||3004||3004|5211||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|3554|lyfalmen|V0334|3076|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||1800||1800|3554||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|4380|lyfalmen|V0335|3076|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||2400||2400|4380||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|1948|3758|lyfalmen|V0222|3758|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||1948||1948|3758||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|305592|380794|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||305592||305592|380794||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|114382|143694|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||114382||114382|143694||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3695|7181|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3695||3695|7181||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1946||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|9818|14000|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||9818||9818|14000||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2919|5094|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2919||2919|5094||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6317|9771|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6317||6317|9771||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|7696|11669|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7696||7696|11669||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|4322|7025|lyfalmen|V0017|7025|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4322||4322|7025||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4891|7808|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4891||4891|7808||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4229|6897|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4229||4229|6897||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|102554|129027|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||102554|129027||1 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1201|2725|lyfalmen|V0545|2016|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1198||1198|2725||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|6444|lyfalmen|V0107|6444|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||3900||3900|6444||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|12759|18680|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||12759||12759|18680||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|14716|21155|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14716||14716|21155||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2153|4040|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2153||2153|4040||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2545|4579|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2545||2545|4579||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1713|3434|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1713||1713|3434||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3425|5790|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3425||3425|5790||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3276|5585|lyfalmen|V0191|4842|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3276||3276|5585||2 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|19961|26612|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19961||19961|26612||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|11039|15548|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11039||11039|15548||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|8643|4018|lyfalmen|V0572|4016|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||2137||2137|4018||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|144436|180961|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||144436||144436|180961||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1461|3087|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1461||1461|3087||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|11812|lyfalmen|V0197|11812|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7800||7800|11812||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|4341|7051|lyfalmen|V0438|7051|2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4341||4341|7051|| 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|19983|23678|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||17595||17595|23678||2 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1436|2475|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1436||1436|2475||1 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|862|2263|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||862||862|2263||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|28574|lyfalmen|V0683|28574|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||20582||20582|28574||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2014||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|8574|16437|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||8574|16437||2 108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13566|18682|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13566||13566|18682||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2445|4442|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2445||2445|4442||2 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|50889|64962|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||50889||50889|64962||1 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3065|5295|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3065||3065|5295||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9095|13595|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9095||9095|13595||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|81099|105116|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||81099||81099|105116||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1444|3064|lyfalmen|V0443|3062|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1444||1444|3064||1 109212|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.12.2014||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17634|5675|lyfalmen|V0516|5446|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3341||3341|5675||1 109357|A02BC0508|Esomeprazol Actavis|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2361|2199|lyfalmen|V0004|2199|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||816||816|2199||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22547|31059|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||22547||22547|31059||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18051|25373|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18051||18051|25373||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|2807|3350|lyfalmen|V0584|3350|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||1652||1652|3350||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|6980|8240|lyfalmen|V0585|8240|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||5205||5205|8240||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|4723|6293|lyfalmen|V0586|6293|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||3790||3790|6293||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|13637|14130|lyfalmen|V0587|14130|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||9484||9484|14130||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|20935|21485|lyfalmen|V0588|21484|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||14977||14977|21485||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|483|1741|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||483||483|1741||2 110094|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|12|stk|1|þpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|10383|5022|lyfalmen|||2|12|0|24,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||2812||2867|5022|30.4.2015|1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2315|lyfalmen|V0291|2315|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2315||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3760|lyfalmen|V0292|3760|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3760||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5343|lyfalmen|V0296|5343|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5343||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6720|lyfalmen|V0297|6720|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6720||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1430|3045|lyfalmen|V0065|1915|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1430||1430|3045||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3656|6108|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3656||3656|6108||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|85663|108082|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||85663||85663|108082||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|4909|7021|lyfalmen|V0373|7021|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4319||4319|7021||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|SLU|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3525|5027|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3525||3525|5027||2 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|696|2034|lyfalmen|V0229|2021|1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||696||696|2034||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|20202|28093|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||20202||20202|28093||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|SEK|15565|22229|lyfalmen|||1|180|0|90,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíð||15565||15565|22229||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188972|236185|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188972||188972|236185||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|40598|40486|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||30000||30000|40486||2 113247|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.03.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|121655|156411|lyfalmen|V0140|156411|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||121655||121655|156411||3 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4655|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4655||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1744|3477|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1744||1744|3477||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7902|11953|lyfalmen|V0024|10750|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||7902||7902|11953||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|23489|32251|lyfalmen|V0024|32251|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||23489||23489|32251||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8005|12094|lyfalmen|V0025|9432|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8005||8005|12094||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2158|3077|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2158||2158|3077||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2921|5097|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2921||2921|5097||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|20362|28296|lyfalmen|V0025|28296|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||20362||20362|28296||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|5464|8597|lyfalmen|V0681|8597|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5464||5464|8597||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5017|7982|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5017||5017|7982||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|464954|578403|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||464954||464954|578403||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|592|1891|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||592||592|1891||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|750|2109|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||750||750|2109||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1234|2775|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1234||1234|2775||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|732|2084|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||732||732|2084||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|21251|28211|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||21251|28211||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|32918|42678|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||32918|42678||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3838|6359|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3838||3838|6359||1 114512|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2061|3913|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2061||2061|3913||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10100|14978|lyfalmen|V0594|14978|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10100||10100|14978||1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5517|8670|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||5517||5517|8670||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|12088|lyfalmen|V0420|12088|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||8000||8000|12088||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5650|9738|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5650||5650|9738||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|2315|4263|lyfalmen|V0278|3396|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2315||2315|4263||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3028|5244|lyfalmen|V0279|3141|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||3028||3028|5244||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10507|15538|lyfalmen|V0280|5379|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10507||10507|15538||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11056|16294|lyfalmen|V0282|2392|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||11056||11056|16294||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7255|7132|lyfalmen|V0457|6582|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4400||4400|7132||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|14207|14152|lyfalmen|V0456|13464|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||9500||9500|14152||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23237|14840|lyfalmen|V0475|14152|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10000||10000|14840||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|35825|19911|lyfalmen|V0540|19911|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|19911||2 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1769|3511|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1769||1769|3511||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8250|11765|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8250||8250|11765||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1390|2464|lyfalmen|V0158|2453|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1008||1008|2464||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10611|15681|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10611||10611|15681||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1769|3511|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1769||1769|3511||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10611|15681|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10611||10611|15681||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|51929|68222|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||51929||51929|68222||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1762|3502|lyfalmen|V0369|2951|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíð||1762||1762|3502||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|3965|6534|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3965||3965|6534||1 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983|30.04.2015|L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3982|5678|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3982||3982|5678||1 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|2082|2969|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2082||2082|2969||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1992|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|18346|12900|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||8590||8590|12900||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|722|1945|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||631||631|1945|31.3.2015|1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|352|1544|lyfalmen|V0563|1544|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||340||340|1544||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|846|2221|lyfalmen|V0564|1714|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||832||832|2221||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|16448|23345|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||16448||16448|23345||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7034|4875|lyfalmen|V0081|4875|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2760||2760|4875||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5605|8791|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5605||5605|8791||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6019|9361|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6019||6019|9361||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|17768|25015|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17768||17768|25015||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|11493|8970|lyfalmen|||2|56|0|56,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||5735||5735|8970||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|902|2318|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||902|2318||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|9107|17448|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||9107||9107|17448||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1581|3252|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1581||1581|3252||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4211|6872|lyfalmen|V0435|6775|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4211||4211|6872||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|13118|16785|lyfalmen|||1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||11413||11413|16785||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|23184|28054|lyfalmen|V0273|24044|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||20171||20171|28054||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1492|3130|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1492||1492|3130||2 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4009|6594|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4009|6594||1 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|37208|43486|lyfalmen|V0272|38026|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||32372||32372|43486||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|46368|61188|lyfalmen|V0261|51869|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||46368|61188||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|52813|67348|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||52813||52813|67348||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9029|15562|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9029||9029|15562||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|6111|11764|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||6111||6111|11764||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10784|20630|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10784||10784|20630||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1685|3396|lyfalmen|V0278|3396|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1685||1685|3396||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2764|4881|lyfalmen|V0279|3141|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2764||2764|4881||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9928|2782|lyfalmen|V0282|2392|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1239||1239|2782||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1630|3320|lyfalmen|V0283|3320|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1630||1630|3320||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13564|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13564||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|16125|5379|lyfalmen|V0280|5379|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3126||3126|5379||1 118525|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|5992|8545|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||5992||5992|8545||2 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5003|9662|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5003||5003|9662||2 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|21480|29710|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||21480||21480|29710||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2983|4254|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2983||2983|4254||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|455|1703|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||455||455|1703||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1461|3087|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1461||1461|3087||1 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|897|1949|lyfalmen|V0309|1949|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||634||634|1949||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|398271|495716|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||398271||398271|495716||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|356247|443606|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||356247||356247|443606||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|1100|2590|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1100||1100|2590||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|40001|51461|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||40001||40001|51461||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|12776|lyfalmen|V0118|12695|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||8500||8500|12776||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|27232|35628|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||27232||27232|35628||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|420795|523646|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||420795||420795|523646||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4990|7945|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4990||4990|7945||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|7133|10172|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíð||7133||7133|10172||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|439|1681|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||439||439|1681||1 121550|A02BC0507|Esomeprazole Portfarma|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|8128|5278|lyfalmen|V0011|5123|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5278||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|501|1766|lyfalmen|V0391|1675|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||501||501|1766||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1637|3329|lyfalmen|V0314|2835|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1637||1637|3329||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|335|1537|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||335||335|1537||1 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9432|16257|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9432||9432|16257||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|621|1931|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||621||621|1931||2 122577|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|2907|3799|lyfalmen|V0381|3799|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1978||1978|3799||2 122588|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14341|11997|lyfalmen|||2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|11997||2 122610|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3320|3712|lyfalmen|V0384|3712|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3712||2 122643|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14341|11997|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|11997||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|820|2205|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||820||820|2205||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1051|2523|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1051||1051|2523||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|30185|52027|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||30185||30185|52027||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|19869|27672|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||19869||19869|27672||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|9000|13464|lyfalmen|V0115|13464|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||9000||9000|13464||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|29616|51046|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||29616||29616|51046||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|228|1390|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||228|1390||1 123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2324|2561|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2324||1079|2561|28.2.2015|2 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|23892|32761|lyfalmen|V0579|26996|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||23892||23892|32761||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1697|3335|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1697|3335||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|31664|42591|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||31664|42591||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|9320|13904|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9320||9320|13904||2 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1779|1910|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||606||606|1910||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2541|2190|lyfalmen|V0233|2190|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||809||809|2190||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|929|2355|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||929||929|2355||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|476|1731|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||476||476|1731||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|10759|15885|lyfalmen|V0464|15885|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||10759||10759|15885||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|968|2270|lyfalmen|V0066|2270|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||867||867|2270||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|12121|17873|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||12121||12121|17873||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|4380|lyfalmen|V0285|4369|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2400||2400|4380||2 125973|D01BA0206|Terbinafin Bluefish|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|XEU|2330|4283|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||2330||2330|4283|30.4.2015|2 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008|31.03.2015|R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|120264|150987|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||120264|150987||1 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008|31.03.2015|R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|30864|40131|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30864|40131||1 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|23614|31141|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||23614||23614|31141||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7871|11224|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7871||7871|11224||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|31845|41348|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||31845||31845|41348||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|63691|80837|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||63691||63691|80837||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|127381|159812|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||127381||127381|159812||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|126031|158138|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||126031||126031|158138||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|36599|48832|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||36599|48832||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3556|5971|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3556|5971||1 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3875|5228|lyfalmen|V0011|5228|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3016||3016|5228||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1668|2370|lyfalmen|V0144|1637|2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||940||940|2370||2 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|3339|lyfalmen|V0313|3339|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1644||1644|3339||2 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8117|5969|lyfalmen|V0279|3141|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3555||3555|5969||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|13427|25644|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||13427||13427|25644||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4644|4472|lyfalmen|||2|56|0|28,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||2467||2467|4472||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1144|2651|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1144||1144|2651||1 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990|30.04.2015|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3571|5092|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3571||3571|5092||2 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2177|lyfalmen|V0003|1643|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|31805|21907|lyfalmen|V0282|2392|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15311||15311|21907||2 129124|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|14976|21484|lyfalmen|V0588|21484|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||14976||14976|21484||1 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|244|1412|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||244||244|1412||1 129483|J01DH0202|Merinfec|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|17150|23126|lyfsjukr|||1|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||17150|23126||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3065||1 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3109|5356|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||3109||3109|5356||1 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|9929|14743|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14743||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2063|3916|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2063||2063|3916||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|16114|30742|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||16114||16114|30742||1 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3712|6186|lyfalmen|V0644|6186|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3712||3712|6186||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1613|3296|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1613||1613|3296||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|10564|15617|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||10564|15617||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|53560|86339|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||53560|86339||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2956|5145|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2956|5145||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|417|1650|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||417||417|1650||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|657|1981|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||657||657|1981||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|875|2281|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||875||875|2281||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|969|2410|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||969||969|2410||1 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5056|8035|lyfalmen|||1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5056||5056|8035||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3650|6100|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||3650||3650|6100||2 131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10950|16148|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||10950||10950|16148||2 131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|36356|48525|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||36356||36356|48525||2 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|7057|10790|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7057||7057|10790||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6783|2974|lyfalmen|V0581|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1379||1379|2974||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3901|2974|lyfalmen|V0580|2728|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1379||1379|2974||1 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|DKK|9351|13947|lyfalmen|||1|28|0|28,0000|Vistor hf|Almirall S.A.|Linaclotídum||9351||9351|13947||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1310|2879|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1310||1310|2879||1 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6155|9443|lyfalmen|V0681|8597|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6079||6079|9443||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|8962|17173|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||8962||8962|17173||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3076|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1254|2802|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1254||1254|2802||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1220|2756|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1220||1220|2756||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|23978|31593|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||23978||23978|31593||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|31882|41394|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||31882||31882|41394||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|43353|55618|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||43353|55618||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|176788|221077|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||176788||176788|221077||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7920|11294|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7920||7920|11294||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6157|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6157||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|3081|5317|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3081||3081|5317||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3363|lyfalmen|V0333|3363|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3363||2 134019|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3076|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134085|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3076|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3720|6197|lyfalmen|V0378|5474|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3720||3720|6197||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|11150|16423|lyfalmen|V0378|16423|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11150||11150|16423||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|2526|3602|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2526||2526|3602||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|55687|70912|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||55687||55687|70912||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2041|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8652||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|111783|140471|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||111783||111783|140471||2 134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|3416|lyfalmen|V0007|3416|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||1700||1700|3416||2 134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3100|3829|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3829||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380669|473890|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380669||380669|473890||2 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|48966|62578|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||48966||48966|62578||1 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|þpakki||C07AG02|01.07.2011|28.02.2015|R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2563|4604|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Carvedílól||2563||2563|4604||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|892|2304|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||892||892|2304||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1447|3068|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1447||1447|3068||1 135559|L01CD0202|Docetaxel Actavis|irþ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|4981|7103|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||4981||4981|7103||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1469|3098|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1469||1469|3098||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|6119|9499|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||6119||6119|9499||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|64489|81826|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||64489||64489|81826||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2997|5201|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2997||2997|5201||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|426|1542|lyfalmen|V0307|1542|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||338||338|1542||2 136964|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2179|3107|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2179||2179|3107||2 136975|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|6823|9730|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||6823||6823|9730||2 136987|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5028|7170|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5028||5028|7170||2 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|7838|11177|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7838||7838|11177||2 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5510|7857|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5510||5510|7857||2 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|51869|lyfalmen|V0261|51869|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||39000||39000|51869||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|20053|26726|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||20053||20053|26726||2 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|5830|8314|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||5830||5830|8314||2 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|5092|7261|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||5092||5092|7261||2 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|5755|8207|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||5755||5755|8207||2 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|690|984|lyfsjukr|||2|1|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||690||690|984||2 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|973|1387|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||973||973|1387||2 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|13290|19351|lyfalmen|V0689|19351|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||13290||13290|19351||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2867|5022|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2867||2867|5022||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1592|3268|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1592||1592|3268||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15912|22667|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||15912||15912|22667||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4380|7021|lyfalmen|V0373|7021|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4319||4319|7021||1 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4883||1 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|313431|390514|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||313431||313431|390514||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1342|2923|lyfalmen|V0266|2100|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1342||1342|2923||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|10304|14637|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10304||10304|14637||1 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|SIG|0|0|0|100|DKK|588|838|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||588||588|838||3 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|77588|147370|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||77588||77588|147370||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1147|2655|lyfalmen|V0413|2392|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1147||1147|2655||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3556|5971|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3556|5971||1 141129|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1190|1697|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1190||1190|1697||2 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3551|5064|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3551||3551|5064||2 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|15338|21942|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||15338|21942||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|48508|63895|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||48508||48508|63895||2 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3867|6399|lyfalmen|V0193|5890|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3867|6399||2 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12429|3497|lyfalmen|V0492|3497|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||1759||1759|3497||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|7954|12024|lyfalmen|V0267|4984|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||7954||7954|12024||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1739|3382|lyfalmen|V0127|3151|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1675||1675|3382||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|21584|28624|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||21584|28624||5 142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||R|0|0|0|0|0|0|LEV|0|0|0|100|XEU|1608|2772|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||1608||1608|2772|28.2.2015|2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|820|2205|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||820||820|2205||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2541|4574|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2541||2541|4574||1 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1334|2912|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1334||1334|2912||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2096|2989|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2096||2096|2989||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|4069|6677|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4069||4069|6677||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|543|1617|lyfalmen|V0542|1617|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||393||393|1617||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1036|2502|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíð||1036||1036|2502||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1361|2950|lyfalmen|V0173|2479|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1361||1361|2950||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6106|9481|lyfalmen|V0387|8388|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6106||6106|9481||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1227|2765|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1227||1227|2765||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|7786|11793|lyfalmen|V0386|8501|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||7786||7786|11793||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|561|1848|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||561||561|1848||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2514|4537|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2514||2514|4537||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1595|3272|lyfalmen|V0174|2855|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1595||1595|3272||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1930|3733|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1930||1930|3733||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21220|29381|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21220||21220|29381||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|64397|81712|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||64397||64397|81712||1 144242|C10AA0106|Simvastatin Bluefish|filmhtfl|80|mg|100|stk|1|þpakki||C10AA01|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5000|3815|lyfalmen|||2|100|0|266,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||1990||1990|3815||2 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|42938|55103|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||42938||42938|55103||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|21469|28482|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||21469||21469|28482||1 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|606|1910|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||606||606|1910||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|72562|91837|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||72562||72562|91837||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1664|3270|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1664||1664|3270||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2524|4959|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2524||2524|4959||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín||||||31.3.2015|1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3883|7537|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3883||3883|7537||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5416|10446|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5416||5416|10446||1 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|5585|8764|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5585||5585|8764||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|29504|39859|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||29504||29504|39859||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|32524|42190|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||32524|42190||1 146207|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2815|4014|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||2815||2815|4014||2 146218|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5719|8155|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||5719||5719|8155||2 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|16550|23474|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||16550||16550|23474||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|725|2074|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||725||725|2074||1 146692|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2188|3120|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2188||2188|3120||2 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2334|3328|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2334||2334|3328||2 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1446|2062|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1446||1446|2062||2 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|4898|7818|lyfalmen|V0691|7818|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4898||4898|7818||1 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|104464|134668|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||104464||104464|134668||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1117|2315|lyfalmen|V0577|2315|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||900||900|2315||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1662|3364|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1662||1662|3364||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|5957|8561|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5438||5438|8561||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|77097|100054|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||77097||77097|100054||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|77097|100054|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||77097||77097|100054||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|407|1536|lyfalmen|V0601|1536|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||334||334|1536||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|789|2162|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||789||789|2162||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|78860|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|78860||5 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6073|8660|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6073||6073|8660||2 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|12731|17646|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||12731||12731|17646||2 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|27235|35631|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||27235||27235|35631||2 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3364|6553|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3364||3364|6553||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3126|5379|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||3126||3126|5379||1 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|966|2406|lyfalmen|V0376|1635|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||966||966|2406||1 149525|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2598|5099|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2598|5099||2 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4655|7483|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4655||4655|7483||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|41020|52725|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||41020|52725||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6082|9448|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6082||6082|9448||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|978|2422|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||978||978|2422||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|14769|21222|lyfalmen|V0606|5123|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14769|21222||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|45601|57470|lyfalmen|V0607|12871|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||43428||43428|57470||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|392|1616|lyfalmen|V0633|1544|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||392||392|1616||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4432|7177|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4432|7177||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4742|3585|lyfalmen|V0148|3575|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1823||1823|3585||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1459|3084|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1459||1459|3084||1 151975|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3554|lyfalmen|V0006|3554|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1800||1800|3554||2 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1082|2461|lyfalmen|V0050|2461|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||1006||1006|2461||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1768|2521|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1768||1768|2521||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|2403|3884|lyfalmen|V0123|3884|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||2040||2040|3884||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2875|5033|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2875||2875|5033||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4614|7427|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4614||4614|7427||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8435|12686|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8435||8435|12686||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2040|lyfalmen|V0033|2026|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2040||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|17494|24668|lyfalmen|V0269|24668|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||17494||17494|24668||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|5481|lyfalmen|V0182|5417|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||3200||3200|5481||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10711|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10711||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1104|2596|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1104||1104|2596||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1582|3254|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1582||1582|3254||1 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|30766|40010|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||30766|40010||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1998|3826|lyfalmen|V0561|3669|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1998||1998|3826||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1397|2999|lyfalmen|V0560|2890|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1397||1397|2999||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2235|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3712||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|198945|248552|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||198945||198945|248552||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|507|1774|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||507|1774||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|30196|40734|lyfalmen|V0452|40734|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||30196||30196|40734||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3814|6326|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3814||3814|6326||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|599|1901|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||599||599|1901||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|975|2418|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||975||975|2418||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|1132|2634|lyfalmen|V0366|2634|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||1132||1132|2634||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|8737|13102|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8737||8737|13102||1 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0668|30351|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|980|2425|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||980||980|2425||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|18832|25212|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||18832||18832|25212||2 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21517|28541|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||21517||21517|28541||2 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26917|35237|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||26917||26917|35237||2 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24558|32312|lyfsjukr|||1|7389|0||Icepharma hf|Fresenius Kabi|Blöndur||24558||24558|32312||2 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24893|32727|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||24893||24893|32727||2 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30170|39271|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||30170||30170|39271||2 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|16055|21768|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||16055||16055|21768||2 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3057|5284|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3057||3057|5284||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23726|31280|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||23726||23726|31280||2 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1417|3027|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1417||1417|3027||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4029|3014|lyfalmen|V0334|3014|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1408||1408|3014||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6466|3014|lyfalmen|V0335|3014|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1408||1408|3014||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|417364|530424|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||417364||417364|530424||2 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5304|3182|lyfalmen|V0604|3182|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||1530||1530|3182||2 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10100|14978|lyfalmen|V0594|14978|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10100||10100|14978||1 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2060|2005|lyfalmen|V0247|1749|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||675||675|2005||1 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3471|3842|lyfalmen|V0248|3364|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||2009||2009|3842||1 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6240|4392|lyfalmen|V0249|3769|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||2409||2409|4392||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16422|23313|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16422||16422|23313||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1412|3020|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1412||1412|3020||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2177|lyfalmen|V0466|1782|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2177||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11270|6991|lyfalmen|V0253|6532|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4297||4297|6991||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|604|1908|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||604||604|1908||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1557|3082|lyfalmen|V0590|3082|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1457||1457|3082||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5956|9274|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5956||5956|9274||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5264|8322|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5264||5264|8322||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5499|8645|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5499||5499|8645||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|383|1603|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||383||383|1603||1 156563|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2188|3120|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2188||2188|3120||2 156574|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1283|1830|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1283||1283|1830||2 156585|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|5992|8545|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||5992||5992|8545||2 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9211|13754|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9211||9211|13754||2 156597|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8026|11445|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8026||8026|11445||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|769|2135|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||769||769|2135||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|10939|20924|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||10939||10939|20924||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2641|4552|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2641||2641|4552||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1414|3023|lyfalmen|V0239|3023|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1414||1414|3023||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6545|10085|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6545||6545|10085||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|1032|1472|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||1032|1472||1 158163|N05AH0405|Seroquel Prolong|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1395|2996|lyfalmen|V0695|2813|1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1395|2996||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|25698|35045|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||25698|35045||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|882|2290|lyfalmen|V0239|1512|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||882||882|2290||1 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|94582|119142|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||94582|119142||1 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|176013|220116|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||176013|220116||1 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|472910|588268|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||||472910|588268||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|42355|54380|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||42355|54380||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|55749|70989|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||55749||55749|70989||1 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988|28.02.2015|R|0|0|0|0|G|0|SIG|0|0|0|100|DKK|798|2175|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||798||798|2175||3 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|911|1909|lyfalmen|V0469|1902|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||605||605|1909||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1962|3356|lyfalmen|V0219|3356|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1656||1656|3356||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3364|5651|lyfalmen|V0220|5651|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3324||3324|5651||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4831|7266|lyfalmen|V0221|7263|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4497||4497|7266||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5399|7885|lyfalmen|V0223|7885|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4947||4947|7885||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0581|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2728||2 159565|J01CR0501|Piperacillin/Tazobactam Actavis|irs|4,5|g|12|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.10.2013|28.02.2015|R|0|1|0|0|0|1|APC|0|0|0|100|XEU|16958|22888|lyfsjukr|||2|12|0|3,4300|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||16958||16958|22888||1 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|467|1719|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||467||467|1719||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1416|3025|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1416||1416|3025||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|127275|159681|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||127275||127275|159681||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3913|7594|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3913||3913|7594||2 160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.05.2014||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5305|2453|lyfalmen|V0010|2067|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2453||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|6994|4212|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2954||2954|4212||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2736|4842|lyfalmen|V0191|4842|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2736||2736|4842||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|828|2216|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||828||828|2216||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1116|2612|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1116||1116|2612||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|552|1836|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||552||552|1836||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|856|1221|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||856||856|1221||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|777|1108|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||777||777|1108||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|564|1853|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||564||564|1853||1 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|4492|7259|lyfalmen|||1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4492||4492|7259||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|56025|73402|lyfalmen|V0452|40734|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||56025||56025|73402||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|11417|16017|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||11417||11417|16017||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|136161|170700|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||136161||136161|170700||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|507139|643971|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||507139||507139|643971||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4735|lyfalmen|V0020|4735|2|180|0|90,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíð||2658||2658|4735||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1784|3532|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1784||1784|3532||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5068|9786|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5068|9786||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2551|2725|lyfalmen|V0041|2725|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1198||1198|2725||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|459|1682|lyfalmen|V0500|1656|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1682||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2102|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2102||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|1902|lyfalmen|V0502|1720|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|1902||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2128|lyfalmen|V0110|2128|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2128||2 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1528|3115|lyfalmen|V0373|2340|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1481||1481|3115||1 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1579|3250|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1579||1579|3250||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9963|14789|lyfalmen|V0661|14789|1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||9963||9963|14789||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|1179|2699|lyfalmen|V0671|2384|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1179||1179|2699||1 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1395|2996|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1395||1395|2996||1 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009|31.03.2015|R|1|0|0|0|G|0|AEA|0|0|0|100|XEU|193|1342|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíð||||193|1342||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5870|9156|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5870||5870|9156||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11827|16525|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11827||11827|16525||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2755|4868|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2755||2755|4868||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|487488|606345|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||487488||487488|606345||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|652|1714|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||463||463|1714||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1564|2611|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1115||1115|2611||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9552|14224|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráð lyf|Pólýstýren súlfónat||9552||9552|14224||1 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012|30.04.2015|R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|293167|365387|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||293167||293167|365387||1 164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3610|5148|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3610||3610|5148||2 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|36722|47395|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||36722||36722|47395||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8935|17122|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||8935||8935|17122||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóður|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|40948|77857|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||40948||40948|77857||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2659|4736|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2659|4736||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8765|13140|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||8765||8765|13140||2 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380669|473890|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380669||380669|473890||2 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1081|2564|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1081||1081|2564||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1278|2835|lyfalmen|V0314|2835|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1278||1278|2835||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|6494|10015|lyfalmen|V0014|9523|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||6494|10015||2 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|1222|2758|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1222||1222|2758||1 165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|22603|31130|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||22603||22603|31130|28.2.2015|1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6447|12402|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6447||6447|12402||2 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4499|7269|lyfalmen|V0059|4831|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4499||4499|7269||1 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|6950|9911|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||6950||6950|9911||1 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2904|5073|lyfalmen|V0058|3483|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||2904||2904|5073||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|165378|206929|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||165378||165378|206929||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30163|39262|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||30163||30163|39262||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|43918|56318|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||43918||43918|56318||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|622|1932|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||622||622|1932||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|180|1324|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||180||180|1324||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188972|236185|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188972||188972|236185||2 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3815|5440|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3815||3815|5440||2 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|58590|74512|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||58590||58590|74512||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4354|8431|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4354|8431||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|424308|539207|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||424308||424308|539207||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1538|3193|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1538||1538|3193||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|14138|20424|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14138||14138|20424||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1970|3788|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1970||1970|3788||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3730|6210|lyfalmen|V0428|6210|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3730||3730|6210||2 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|121655|156411|lyfalmen|V0140|156411|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||121655||121655|156411||3 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|419|1653|lyfalmen|V0333|785|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||419||419|1653||1 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1672|2440|lyfalmen|V0005|2440|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||991||991|2440||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|164838|206259|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||164838||164838|206259||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|568|1858|lyfalmen|V0119|1627|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||568|1858||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3650|lyfalmen|V0007|3348|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3650||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4168|6813|lyfalmen|V0621|1757|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4168||4168|6813||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2195|4098|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2195||2195|4098||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2351|4312|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2351||2351|4312||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2583|4632|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2583||2583|4632||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2920|5095|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2920||2920|5095||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3075|5309|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3075||3075|5309||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2840|4985|lyfalmen|V0240|4984|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2840||2840|4985||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5242|8291|lyfalmen|V0433|8289|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5242||5242|8291||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|27489|35946|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||27489||27489|35946||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|11700|17180|lyfalmen|V0688|17180|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||11700||11700|17180||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|137444|172291|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||137444||137444|172291||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|19195|25662|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||19195||19195|25662||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5710|8936|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5710||5710|8936||1 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2936|lyfalmen|V0124|2936|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2936||1 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|2852|lyfalmen|V0125|2603|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||1290||1290|2852||1 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2684|lyfalmen|V0411|2684|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2684||1 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1967|lyfalmen|V0177|1967|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1967||1 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1954|lyfalmen|V0418|1954|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1954||1 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1617|lyfalmen|V0176|1617|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1617||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2620|4682|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2620||2620|4682||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2821|4959|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2821||2821|4959||1 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|18462|24753|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||18462|24753||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|45716|58548|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||45716|58548||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|6139|9526|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6139||6139|9526||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|91434|115238|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||91434||91434|115238||2 170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3215|5501|lyfalmen|V0618|5501|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3215|5501||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|14930|21425|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||14930||14930|21425||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2144|4027|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2144||2144|4027||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|10662|15081|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||10662||10662|15081||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|25647|33662|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||25647||25647|33662||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|38471|49564|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||38471||38471|49564||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3131|2790|lyfalmen|V0203|2790|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1245||1245|2790||1 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||896||896|2310||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|53661|68400|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||53661||53661|68400||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2548|5005|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2548||2548|5005||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3248|5547|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3248||3248|5547||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3280|5591|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3280||3280|5591||1 171765|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1361|2675|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1361|2675||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2715|4813|lyfalmen|V0247|1749|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2715||2715|4813||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4746|7609|lyfalmen|V0248|3364|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4746||4746|7609||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|41681|53544|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||41681||41681|53544||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|27788|36317|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||27788||27788|36317||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8659|12995|lyfalmen|V0249|3769|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8659||8659|12995||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|15804|22531|lyfalmen|V0252|17553|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||15804||15804|22531||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|63912|81111|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||63912||63912|81111||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0346|33490|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|17738|30573|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||17738||17738|30573||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20929|29013|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||20929||20929|29013||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|10321|15282|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||10321||10321|15282||1 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5921|9226|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||5921||5921|9226||2 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|10999|16215|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||10999||10999|16215||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2840|2153|lyfalmen|V0284|2153|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||782||782|2153||1 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19083|26678|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||19083||19083|26678||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|569656|723043|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||569656||569656|723043||1 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|24885|34017|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||24885||24885|34017||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|372|1588|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||372||372|1588||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9925|12441|lyfalmen|V0118|12441|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||8257||8257|12441||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3086|5324|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||3086||3086|5324||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3506||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5460|8591|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||5460||5460|8591||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|12315|17131|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||12315||12315|17131||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|13443|18529|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||13443||13443|18529||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1781|2540|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1781||1781|2540||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|599|1901|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||599||599|1901||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1280|2838|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1280||1280|2838||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|612|1919|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||612||612|1919||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|1582|3254|lyfalmen|V0368|2487|1|5|0|25,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||1582||1582|3254||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5068|lyfalmen|V0634|5068|2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5068|| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|4638|7460|lyfalmen|V0368|7460|1|15|0|75,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||4638||4638|7460||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2813|lyfalmen|V0695|2813|2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2813||2 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4984|9626|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4984||4984|9626||2 175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2728|lyfalmen|V0065|1915|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||1200||1200|2728||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2715|2409|lyfalmen|V0033|2026|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||968||968|2409||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6184|4813|lyfalmen|V0278|3396|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2715||2715|4813||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5507|8133|lyfalmen|V0429|8133|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5127||5127|8133||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2567|4610|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2567||2567|4610||1 176862|C07AG0204|Carvedilol HEXAL|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.01.2015||R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2034|3876|lyfalmen|||2|100|1|16,6700|Distica|Distica - óskráð lyf|Carvedílól||2034||2034|3876||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8051|11481|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8051||8051|11481||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1070|2549|lyfalmen|V0231|2549|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1070||1070|2549||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4278|8287|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4278||4278|8287||2 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2071|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||723||723|2071||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|36356|48525|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||36356||36356|48525||2 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|4793|lyfalmen|V0320|4793|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2700||2700|4793||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|131964|165495|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||131964||131964|165495||1 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10065|14930|lyfalmen|||2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||10065||10065|14930|31.3.2015|2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10287|15235|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10287|15235||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16650|23601|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16650||16650|23601||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|109058|137092|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||109058||109058|137092||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5215|8254|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5215||5215|8254||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2427|3972|lyfalmen|V0148|3972|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||2104||2104|3972||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|742|2098|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||742||742|2098||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7490|14381|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7490||7490|14381||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9105|12984|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9105||9105|12984||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5699|8920|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5699||5699|8920||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5960||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|12063|17799|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12063||12063|17799||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|11537|lyfalmen|V0020|4735|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||7600||7600|11537||2 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|15943|21629|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15943||15943|21629||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|19280|36749|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||19280|36749||2 182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|32187|43252|lyfalmen|V0636|43016|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||32187||32187|43252||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5021|9696|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5021||5021|9696||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1779|1910|lyfalmen|V0234|1910|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||606||606|1910||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5391|8496|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5391|8496||1 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012|30.04.2015|R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|1172669|1455970|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1172669||1172669|1455970||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1107|2600|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1107||1107|2600||1 184014|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|6056|9412|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||6056||6056|9412||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|548|1831|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||548||548|1831||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1603|2312|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||898||898|2312||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4371|7093|lyfalmen|V0017|7025|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4371|7093||2 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|20235|28135|lyfalmen|V0170|6458|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||20235||20235|28135||1 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|51425|67584|lyfalmen|V0185|13860|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||51425||51425|67584||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1266|2819|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1266||1266|2819||1 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|4728|7584|lyfalmen|V0235|6016|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||4728||4728|7584||1 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Medical ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|899|2314|lyfalmen|V0597|2314|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||899||899|2314||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|33833|13457|lyfalmen|V0607|13134|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||8995||8995|13457||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5802|9062|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5802||5802|9062||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3192|3829|lyfalmen|V0462|3829|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5451|9395|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5451||5451|9395||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4079|6691|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4079||4079|6691||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2705||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|71869|90978|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||71869||71869|90978||2 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3142|1855|lyfalmen|V0621|1757|2|6|0|6,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||566||566|1855||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2735|4841|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2735||2735|4841||1 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972|31.03.2015|R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2771|4890|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2771||2771|4890||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|8989|12818|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||8989||8989|12818||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|42854|54999|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||42854||42854|54999||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6667|9507|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6667||6667|9507||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2323|4274|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2323||2323|4274||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|956|2392|lyfalmen|V0413|2392|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||956||956|2392||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|463|1714|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||463||463|1714||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|429|612|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||429||429|612||1 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|252|1423|lyfalmen|V0642|1423|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||252||252|1423||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|7448|11328|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||7448|11328||2 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1719|3442|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1719||1719|3442||1 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|þpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1038|2505|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1038||1038|2505||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0149|2563|0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2563||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3597|5129|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3597||3597|5129||2 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6534|7761|lyfalmen|V0117|7761|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||4857||4857|7761||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3389|4833|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3389||3389|4833||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3535|5041|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3535||3535|5041||2 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 191587|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8026|11445|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8026||8026|11445||2 191742|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3983|6559|lyfalmen|V0201|5486|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3983||3983|6559||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|485|1744|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||485||485|1744||2 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3574|5996|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3574||3574|5996||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|5970|8133|lyfalmen|V0429|8133|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||5127||5127|8133||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1496|3135|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1496||1496|3135||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|6082|9448|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||6082||6082|9448||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7048|10050|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7048||7048|10050||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|1|0|100|SEK|165643|207257|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||165643||165643|207257||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2541|2190|lyfalmen|V0233|2190|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||809||809|2190||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|916|2337|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||916||916|2337||1 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2338||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|46463|74898|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||46463||46463|74898||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1902|lyfalmen|V0556|1872|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1902||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5106|9858|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5106||5106|9858||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6060|5272|lyfalmen|V0012|5272|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3048||3048|5272||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1628|3317|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1628||1628|3317||2 195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13352|19430|lyfalmen|V0609|19430|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13352||13352|19430||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 195472|A02BC0507|Esomeprazole Portfarma|sþ-tfl|40|mg|98|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9142|6000|lyfalmen|V0012|5167|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3577||3577|6000||1 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|55126|70216|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||55126||55126|70216||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|130889|164162|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||130889||130889|164162||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|938|2367|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||938||938|2367||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|670|1999|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||670||670|1999||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|344|1550|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||344||344|1550||1 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|728|2078|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||728||728|2078||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2080|3939|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2080||2080|3939||2 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1432|3047|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1432||1432|3047||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1681|3390|lyfalmen|||2|100|0|75,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3390||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|8484|12748|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||8480||8480|12748||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|20510|27292|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||20510|27292||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|575|1627|lyfalmen|V0119|1627|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||400||400|1627||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|0|0|1|0|1|SCO|0|1|0|100|XEU|59142|75196|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||59142||59142|75196||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|793|2168|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||793||793|2168||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2594|4647|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2594||2594|4647||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1889|3676|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1889||1889|3676||1 198220|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7490|14381|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7490||7490|14381||2 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2212|3003|lyfalmen|V0069|3003|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lósartan||1400||1400|3003||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6640|9469|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6640||6640|9469||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|33370|44748|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||33370||33370|44748||1 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7904|4082|lyfalmen|V0515|4082|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2184||2184|4082||1 199319|A10BG0304|Pioglitazone Accord|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|6792|4016|lyfalmen|V0572|4016|2|98|0|49,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||2136||2136|4016||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|585|1882|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||585||585|1882||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|87145|109920|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||87145|109920||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4320|7022|lyfalmen|V0126|7022|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4320||4320|7022||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|49599|63363|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||49599||49599|63363||2 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2389076|2964314|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2389076||2389076|2964314||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|579|826|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||579||579|826||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|30792|58589|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30792||30792|58589||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2743|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2743||2 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|543|774|lyfsjukr|||1|1|0|0,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||543||543|774||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|8858|13268|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||8858||8858|13268||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9398||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3905|6451|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3905||3905|6451||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3385|5735|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3385||3385|5735||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|PTL|0|0|0|100|DKK|2321|4271|lyfalmen|||1|66|0|66,0000|Navamedic AB|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2321||2321|4271||1 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|13090|19098|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||13090||13090|19098||1 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4389|7117|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4389||4389|7117||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6811|10451|lyfalmen|V0436|10451|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||6811||6811|10451||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8931|13369|lyfalmen|V0437|13369|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||8931||8931|13369||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|6903|7668|lyfalmen|V0420|4029|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||4789||4789|7668||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|433|1469|lyfalmen|V0541|1469|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||285||285|1469||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1462|3089|lyfalmen|V0126|1756|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1462||1462|3089||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|344819|429436|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||344819||344819|429436||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|501|1766|lyfalmen|V0500|1656|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||501||501|1766||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5306|7566|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5306||5306|7566||2 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6857|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6857||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|19539|27255|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||19539||19539|27255||2 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4268|6951|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4268||4268|6951||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|12241|18024|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12241||12241|18024||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4223|6889|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4223||4223|6889||2 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7032|10755|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7032||7032|10755||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|8299|12499|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8299||8299|12499||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|9720|14455|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9720||9720|14455||1 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|27497|37320|lyfalmen|V0459|37320|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||27497||27497|37320||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8180|12335|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||8180||8180|12335||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|18387|25798|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||18387||18387|25798||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|86436|111866|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||86436||86436|111866||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|806695|1002162|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||806695||806695|1002162||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11820|20373|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11820||11820|20373||2 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|3969|6539|lyfalmen|V0116|4793|1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3969||3969|6539||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|11856|8503|lyfalmen|V0182|5417|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5396||5396|8503||1 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2360|4325|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2360||2360|4325||1 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|15193|21758|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||15193||15193|21758||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1640|3334|lyfalmen|V0677|3334|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1640||1640|3334||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7711|13291|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||7711||7711|13291||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|144780|181387|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||144780|181387||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|92793|116923|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||92793||92793|116923||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|122057|153211|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||122057||122057|153211||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|157628|197319|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||157628||157628|197319||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|133717|167669|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||133717||133717|167669||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|8520|6106|lyfalmen|V0532|6106|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3654||3654|6106||1 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1552|3212|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1552||1552|3212||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2072|3928|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2072||2072|3928||1 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|19351|27017|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19351||19351|27017||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1505|3148|lyfalmen|V0676|3148|1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1505||1505|3148||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27357|37143|lyfalmen|V0653|37143|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27357|37143||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25308|lyfalmen|V0195|25308|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25308||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|10516|5489|lyfalmen|V0606|5489|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||3206||3206|5489||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2944|5074|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2944||2944|5074||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7070|4402|lyfalmen|V0143|4402|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2416||2416|4402||2 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15056|10308|lyfalmen|V0533|10308|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||6707||6707|10308||1 382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3662|4197|lyfalmen|V0141|4197|2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||2267||2267|4197||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4671|7505|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4671||4671|7505||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|6190|9596|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6190||6190|9596||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1191|2053|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1191||1191|2053||2 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7173|12363|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7173||7173|12363||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2050|3898|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2050||2050|3898||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|36696|47363|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||36696||36696|47363||1 385214|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|25|lykja|dreifa|H02AB01|01.07.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|10392|15380|lyfalmen|||1|25|0|116,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||10392||10392|15380||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7818|11837|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7818||7818|11837||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5718|3513|lyfalmen|V0144|3275|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1770||1770|3513||2 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|51118|67196|lyfalmen|V0184|5263|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||51118||51118|67196||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|29132|25153|lyfalmen|V0111|25153|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Eplerenón||17877||17877|25153||2 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|9051|13534|lyfalmen|V0670|13534|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||9051||9051|13534||1 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|862|2015|lyfalmen|V0308|2015|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||682||682|2015||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|107804|135537|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||107804||107804|135537||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5353|10326|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5353||5353|10326||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12429|6125|lyfalmen|V0491|6125|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||3668||3668|6125||2 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|141068|176784|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||141068||141068|176784||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2943|5127|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2943||2943|5127||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3709|6181|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3709||3709|6181||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.04.2013||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|7273|10371|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||7273||7273|10371||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|7198|10984|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||7198||7198|10984||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2257|1782|lyfalmen|V0466|1782|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||513||513|1782||1 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2494|4509|lyfalmen|V0410|4509|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2494||2494|4509||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1873|3654|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1873||1873|3654||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|736|2089|lyfalmen|V0128|2089|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||736||736|2089||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|550|1833|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||550||550|1833||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|832|2221|lyfalmen|V0367|1629|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||832||832|2221||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2501|2147|lyfalmen|V0143|1467|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||778||778|2147||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3612|4984|lyfalmen|V0267|4984|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2839||2839|4984||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|44137|58366|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||44137|58366||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|AGT|0|0|0|100|SEK|336|1207|lyfalmen|V0312|1207|2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Zópíklón||95||95|1207||1 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|17194|24289|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||17194||17194|24289||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|76235|96391|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||76235||76235|96391||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2715|4813|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2715||2715|4813||1 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|2829|1949|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||634||634|1949||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6505|10030|lyfalmen|V0429|8133|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6505||6505|10030||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2569|4612|lyfalmen|V0037|3641|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2569||2569|4612||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|22983|31611|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||22983|31611||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|12536|18398|lyfalmen|V0196|14674|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||12536||12536|18398||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1374660|1706438|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1374660|1706438||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|321613|254886|lyfsjukr|||2|30|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||204053||204053|254886||1 391730|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2370|4338|lyfalmen|V0656|4338|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2370||2370|4338||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2259|4186|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2259||2259|4186||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|683|2016|lyfalmen|V0545|2016|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||683||683|2016||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|198611|248138|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||198611||198611|248138||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4247|5651|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3324||3324|5651||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|43949|56357|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||43949||43949|56357||2 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|10800|15941|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10800||10800|15941||1 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|9679|lyfalmen|V0286|6382|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||6250||6250|9679||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|79789|103459|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||79789||79789|103459||2 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5224|10081|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5224||5224|10081||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|2241|4161|lyfalmen|V0669|4161|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Travóprost||2241||2241|4161||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394357|A10BX0205|Repaglinide Accord|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.04.2014|31.03.2015|R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|||lyfalmen|||2|90|0|22,5000|Portfarma ehf|Accord Healthcare Limited|Repaglíníð||||||| 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|138206|172168|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||137345||137345|172168||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5945|9259|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5945||5945|9259||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3895|3691|lyfalmen|V0679|3691|2|98|0|196,0000|Medical ehf|ratiopharm GmbH|Valsartan||1900||1900|3691||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|19053|26640|lyfalmen|V0356|26144|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||19053||19053|26640||3 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|166727|208601|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||166727||166727|208601||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4601|7409|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4601||4601|7409||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3765|6258|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3765||3765|6258||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|19799|37733|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||19799||19799|37733||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5229|10091|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5229||5229|10091||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1177|2696|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1177||1177|2696||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|26577|34815|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||26577||26577|34815||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|5131|7317|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||5131||5131|7317||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|29506|38447|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||29506||29506|38447||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5406||1 398698|N05AH0412|Quetiapin Sandoz|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|41775|55370|lyfalmen|V0261|51869|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Quetíapín||41768||41768|55370||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3829|lyfalmen|V0012|2952|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3281|3660|lyfalmen|V0009|3457|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||1877||1877|3660||2 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|350|1558|lyfalmen|V0225|1540|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||350||350|1558||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2310|lyfalmen|V0244|2001|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2310||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8388|12622|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8388||8388|12622||1 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33293|43143|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33293|43143||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|106020|133325|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||106020||106020|133325||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1242|2786|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1242||1242|2786||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4790|7669|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4790||4790|7669||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|208|1363|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||208||208|1363||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|377|1595|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||377||377|1595||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|180|1324|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||180||180|1324||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5012|7975|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5012||5012|7975||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|175794|219845|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||175794||175794|219845||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2175|3641|lyfalmen|V0037|3641|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1863||1863|3641||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|9500|14152|lyfalmen|V0459|12440|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9500||9500|14152||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|705|2047|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||705||705|2047||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1128|2629|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1128||1128|2629||1 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2499|4034|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2149||2149|4034||1 402395|N06DX0103|Nemdatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2013|31.03.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|38013|16098|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||10914||10914|16098||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1848|3632|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1848||1848|3632||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|13088|19096|lyfalmen|V0349|19096|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13088||13088|19096|| 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3279|lyfalmen|V0552|3168|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3279||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4777|9233|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4777||4777|9233||1 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5455|8585|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5455||5455|8585||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|34368|44476|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||34368|44476||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1185|2707|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1185||1185|2707||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1899||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|60534|76922|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||60534||60534|76922||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1109|2603|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1109||1109|2603||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|636|907|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||636||636|907||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10514|15548|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10514||10514|15548||1 405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|924|2348|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||924||924|2348||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|2177|lyfalmen|V0559|2177|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||800||800|2177||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2941|5069|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2941||2941|5069||2 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7638|14661|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7638||7638|14661|30.4.2015|2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1906|3700|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1906||1906|3700||1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|20315|28236|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20315||20315|28236||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3392|4837|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3392||3392|4837||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|17061|24121|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||17061||17061|24121||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|468|1720|lyfalmen|V0502|1720|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||468||468|1720||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19004|26578|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19004||19004|26578||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|57298|75013|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||57298||57298|75013||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|67262|87615|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||67262||67262|87615||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|67215|85207|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||67215||67215|85207||1 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|156|1291|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||156||156|1291||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|338|1542|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||338||338|1542||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|15820|22551|lyfalmen|||1|100|0|25,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||15820||15820|22551||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|4853|lyfalmen|V0020|2368|2|90|0|45,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Glíklazíð||2744||2744|4853||1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1821|2907|lyfalmen|V0310|2907|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1330||1330|2907||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2669|4750|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2669||2669|4750||1 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977|28.02.2015|R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2195|4098|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2195||2195|4098||1 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3058|5271|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3058||3058|5271||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|3971|6542|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3971||3971|6542||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3758|6249|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3758||3758|6249||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|11564|16993|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||11564||11564|16993||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|69043|89868|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||69043||69043|89868||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9370|13973|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9370||9370|13973||1 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16132|22946|lyfalmen|V0651|22944|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16132||16132|22946||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|10612|14674|lyfalmen|V0196|14674|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||9879||9879|14674||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5075|8062|lyfalmen|V0620|5729|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5075||5075|8062||1 410173|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2887|4915|lyfalmen|V0598|4915|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2789||2789|4915||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3638|5163|lyfalmen|V0093|5163|2|100|0|133,3300|Portfarma ehf|Orion Corporation|Spírónólaktón||2969||2969|5163||1 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|51268|65432|lyfsjukr|||2|1|0|26,6700|Portfarma ehf|Celltrion Healthcare Hungary Kft.|Infliximab||51268||51268|65432||2 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1008|2464|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1008||1008|2464||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RGM|0|0|0|100|IKR|820|2205|lyfalmen|||2|14|0|7,0000|Medical ehf|ratiopharm GmbH|Valsartan||820||820|2205||2 410757|V03AE0203|Sevelamercarbonat W&H|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.04.2015||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|21075|27392|lyfalmen|V0680|27392|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||19647||19647|27392||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|602|1905|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||602||602|1905||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1645|3340|lyfalmen|V0557|3340|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1645||1645|3340||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|450|1621|lyfalmen|V0230|1612|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||396||396|1621||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4530|6460|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4530||4530|6460||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|7959|8341|lyfalmen|V0624|8341|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5278||5278|8341||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|27002|35342|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||27002||27002|35342||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1871||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7899|11949|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7899||7899|11949||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|19392|27069|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||19392||19392|27069||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3115|4442|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3115||3115|4442||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2896|5665|vetalmen|||0|100|0||Vistor hf|Merial|||2896||2896|5665||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4595|8888|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4595||4595|8888||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|96001|120901|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||96001||96001|120901||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|53697|70458|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||53697||53697|70458||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|3027|5243|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||3027||3027|5243||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3123|5375|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3123||3123|5375||2 413177|N05AH0412|Quetiapin Sandoz|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|24326|25164|lyfalmen|V0273|24044|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Quetíapín||17886||17886|25164||1 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|31302|40674|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||31302||31302|40674||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1765|lyfalmen|V0062|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|17484|7463|lyfalmen|V0342|7314|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4640||4640|7463||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|3998|6579|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||3998||3998|6579||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1228|2767|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1228||1228|2767||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1712|3433|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1712||1712|3433||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188972|236185|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188972||188972|236185||2 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|9840|6532|lyfalmen|V0253|6532|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3964||3964|6532||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1765|3469|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1765||1765|3469||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8823|9086|lyfalmen|V0088|2357|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5819||5819|9086||1 416494|A02BC0507|Esomeprazole Portfarma|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.11.2011|31.03.2015|R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2453|lyfalmen|||2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1000||1000|2453||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.10.2014||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|8234|lyfalmen|V0657|8234|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||5200||5200|8234||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4935|7869|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4935||4935|7869||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2693|4783|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2693||2693|4783||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1206|2736|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1206||1206|2736||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|4977|lyfalmen|V0285|4369|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||2834||2834|4977||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|44196|56663|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||44196||44196|56663||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|92361|116388|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuþáttur IX||92361||92361|116388||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|31833|42804|lyfalmen|V0460|42804|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||31833|42804||1 418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3908|6455|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||3908||3908|6455||2 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|125161|157060|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||125161||125161|157060||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|6137|9523|lyfalmen|V0014|9523|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||6137||6137|9523||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2186|4085|lyfalmen|V0458|4085|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||2186||2186|4085||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2566|4608|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2566||2566|4608||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6611|10176|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6611||6611|10176||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|46259|59221|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||46259||46259|59221||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|3450|5825|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3450||3450|5825||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|34946|45193|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||34946||34946|45193||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|893|2305|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||893||893|2305||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|11207|16502|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11207||11207|16502||1 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1001|2454|lyfalmen|V0036|2453|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1001||1001|2454||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|31452|59841|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||31452||31452|59841||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2186|4085|lyfalmen|V0458|4085|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||2186||2186|4085||2 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|565|1854|lyfalmen|V0596|1854|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||565||565|1854||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1342|2923|lyfalmen|V0051|2177|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1342||1342|2923||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3014|5225|lyfalmen|V0049|3569|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3014||3014|5225||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4956|7898|lyfalmen|V0054|6146|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||4956||4956|7898||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|63140|80154|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||63140||63140|80154||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|3339|5672|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||3339||3339|5672||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|8880|13299|lyfalmen|||1|56|0|14,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8880||8880|13299||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3095|5336|lyfalmen|V0192|4316|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3095|5336||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3829|lyfalmen|V0011|2928|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3829||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|723|2071|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum með öðrum efnum||723||723|2071||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|20379|27130|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||20379||20379|27130||1 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|955|2391|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||955||955|2391||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4052|5778|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4052||4052|5778||1 425679|C07AG0204|Carvedilol HEXAL|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.01.2015||R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|3625|6066|lyfalmen|||2|100|1|66,6700|Distica|Distica - óskráð lyf|Carvedílól||3625||3625|6066||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|4000|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|4000||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|599|1901|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||599||599|1901||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|782|2153|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||782||782|2153||1 426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|þpakki||N03AX14|01.02.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|2129|2109|lyfalmen|V0515|2041|2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||750||750|2109||2 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8337|12551|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8337||8337|12551||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|7822|11843|lyfalmen|V0658|11843|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||7822||7822|11843||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2846||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|20882|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|20882||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0136|1773|0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1773||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39589|50950|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39589|50950||1 428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|||lyfalmen|||2|100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||||||| 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|28356|31362|lyfalmen|V0344|31362|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31362||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3504|4997|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3504||3504|4997||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|89755|113156|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||89755||89755|113156||1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3797|6303|lyfalmen|V0093|5163|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3797||3797|6303||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|10870|16038|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10870||10870|16038||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|982|1400|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||982||982|1400||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1341|1912|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1341||1341|1912||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4158|8059|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4158||4158|8059||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|89895|113330|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||89895||89895|113330||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|27285|5263|lyfalmen|V0184|5263|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||3042||3042|5263||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2761|2348|lyfalmen|V0144|1637|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||924||924|2348||2 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2284|4220|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2284||2284|4220||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|1019|2479|lyfalmen|V0173|2479|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||1019||1019|2479||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|707|2049|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||707||707|2049||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9110|13615|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9110||9110|13615||1 431495|L01CD0201|Taxotere|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|139910|175348|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||139910||139910|175348||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1314|2885|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1314|2885||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4075|6685|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4075||4075|6685||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|0|1|0|0|0|PUT|0|0|0|100|IKR|11696|17175|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17175||2 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2109|3979|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2109||2109|3979||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|7545|lyfalmen|V0693|7545|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4700||4700|7545||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|29513|39870|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||29513|39870||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2918|5707|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2918||2918|5707||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1755||1 433194|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1645|3340|lyfalmen|V0557|3340|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1645||1645|3340||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10278|15223|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10278||10278|15223||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2404|4385|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2404||2404|4385||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5262|8319|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5262||5262|8319||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|162981|203956|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||162981||162981|203956||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|17099|9479|lyfalmen|V0605|6261|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||6105||6105|9479||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|6501|2288|lyfalmen|V0490|2288|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||880||880|2288||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|79294|121351|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||75280||75280|121351||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|8308|12511|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||8308||8308|12511||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|4021|3691|lyfalmen|V0010|3617|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1900||1900|3691||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|795|2171|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||795||795|2171||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5016|7980|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5016||5016|7980||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5016|7980|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5016||5016|7980||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|9573|14253|lyfalmen|V0315|6038|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9573||9573|14253||2 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8747|lyfalmen|V0304|8747|2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8747||2 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|202452|252900|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||202452||202452|252900||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3287|5601|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3287||3287|5601||1 436042|R03DC0305|Montelukast Navamedic|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6630|6940|lyfalmen|V0491|6125|2|98|0|49,0000|Artasan ehf|Navamedic ASA|Montelúkast||4260||4260|6940||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|40087|51568|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||40087||40087|51568||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|689|2025|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||689||689|2025||1 436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|15848|6348|lyfalmen|V0605|6136|2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||3830||3830|6348||2 436877|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|225034|280902|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||225034||225034|280902||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|849|2245|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||849||849|2245||1 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972|30.04.2015|R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3146|5406|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3146||3146|5406||1 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|7784|6627|lyfalmen|V0029|6627|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4033||4033|6627||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2 437774|N06DX0103|Nemdatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.07.2013|31.03.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|17776|7722|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||4828||4828|7722||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|58204|74033|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||58204||58204|74033||2 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1386|2984|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1386||1386|2984||1 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10320|15281|lyfalmen|V0334|3014|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10320||10320|15281||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10082|6157|lyfalmen|V0605|6136|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3691||3691|6157||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|224757|263836|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||211271||211271|263836||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|SIV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Bayer AB|Lóratadín|||||||1 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|SIV|0|0|1|100|DKK|||lyfalmen|V0362|2041|1|100|0|100,0000|Vistor hf|Bayer AB|Lóratadín|||||8652||1 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|152933|191497|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||152933||152933|191497||1 439198|N04BC0505|Oprymea|forðatfl|0,26|mg|10|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|1300|2866|lyfalmen|V0634|1689|2|10|0|1,0400|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||1300||1300|2866||2 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2787|4912|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2787||2787|4912|31.3.2015|1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7593|11527|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||7593||7593|11527||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|20535|28515|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||20535||20535|28515||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2607|4665|lyfalmen|V0658|3948|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2607||2607|4665||1 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439908|G03AA0904|Denise|töflur|||126|stk|1|þpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|3829|lyfalmen|V0065|3829|2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2000||2000|3829||2 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2314|lyfalmen|V0163|1968|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1309|1867|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1309||1309|1867||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2065|2945|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2065||2065|2945||1 440713|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|þpakki||A02BC05|01.06.2014|30.04.2015|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3964|5323|lyfalmen|||2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3085||3085|5323||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|860|2260|lyfalmen|V0046|1982|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||860||860|2260||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1086|2571|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1086||1086|2571||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|977|2421|lyfalmen|V0046|1982|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||977||977|2421||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|112385|141217|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||112385||112385|141217||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|978|2422|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||978||978|2422||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|13456|19561|lyfalmen|V0283|3320|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13456||13456|19561||2 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10611|15681|lyfalmen|V0460|14268|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10611|15681||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3204|5486|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3204||3204|5486||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1251|2459|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1251||1251|2459||2 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|24429|33440|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||24429||24429|33440||1 443500|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3315|4727|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3315||3315|4727||1 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4793|lyfalmen|V0116|4793|2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4793||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7073|10812|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7073||7073|10812||1 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|1064|2541|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1064||1064|2541||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|2904|5073|lyfalmen|V0061|3273|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2904||2904|5073||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|22610|29896|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||22610||22610|29896||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2317|4265|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2317||2317|4265||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2250|4173|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2250||2250|4173||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|5131|8139|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||5131||5131|8139||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6392|9874|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||6392||6392|9874||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1475|3107|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1475||1475|3107||1 445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 445479|N04BC0407|Ropinirol Actavis|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8027|6106|lyfalmen|V0532|6106|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||3654||3654|6106||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6296|9742|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||6296|9742||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|17282|24400|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||17282||17282|24400||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|23411|lyfalmen|V0694|23411|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||16500||16500|23411||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9838|14617|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9838||9838|14617||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5606|8792|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5606||5606|8792||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|6939|10627|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6939||6939|10627||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|998|2450|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||998|2450||2 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8258|12443|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8258||8258|12443||1 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1765|lyfalmen|V0330|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5618|lyfalmen|V0171|5618|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5618||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2782|4905|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2782|4905||2 448217|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|693|2030|lyfalmen|V0675|2030|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||693||693|2030||2 448233|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1270|2824|lyfalmen|V0674|2824|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1270||1270|2824||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1967|3784|lyfalmen|V0202|3387|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1967||1967|3784||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1068|1523|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1068||1068|1523||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5800|8784|lyfalmen|V0686|8784|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||5600||5600|8784||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1238|2780|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1238||1238|2780||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|4896|6982|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4896||4896|6982||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3650|6100|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3650||3650|6100||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|5015|7979|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5015||5015|7979||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4349|8421|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4349||4349|8421||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1143|2650|lyfalmen|V0659|2650|1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1143||1143|2650||1 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|þpakki|875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2314|lyfalmen|V0169|1687|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2314||1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|125373|157323|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||125373||125373|157323||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2535|3683|lyfalmen|V0313|3339|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1894||1894|3683||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|7223|12450|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7223||7223|12450||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|19916|26556|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||19916|26556||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|39723|51117|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||39723||39723|51117||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|44534|58869|lyfalmen|||1|1|0|26,6700|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||44534||44534|58869||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44163|56622|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||44163||44163|56622||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|58885|74877|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||58885||58885|74877||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|45086|59567|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||45086||45086|59567||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|7648|11603|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||7648||7648|11603||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1362|2951|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1362||1362|2951||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10398|17922|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10398||10398|17922||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2453|lyfalmen|V0010|2067|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|10562|15614|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||10562||10562|15614||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|7679|10950|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||7679||7679|10950||2 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2200|4104|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2200||2200|4104|30.4.2015|1 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1436|3053|lyfalmen|V0597|2314|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1436||1436|3053||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3872|6406|lyfalmen|V0598|4915|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3872||3872|6406||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2730|4834|lyfalmen|V0584|3350|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2730||2730|4834||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1374|2368|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1374||1374|2368||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7432|11306|lyfalmen|V0585|8240|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7432||7432|11306||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5263|8320|lyfalmen|V0586|6293|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||5263||5263|8320||2 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|14667|21093|lyfalmen|V0587|14130|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||14667||14667|21093||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2559|3649|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2559||2559|3649||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2972|5167|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2972||2972|5167||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14257|20574|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14257||14257|20574||1 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|40448|36671|lyfalmen|V0341|7314|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||26984||26984|36671||1 454491|A02BC0507|Esomeprazole Portfarma|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2209|lyfalmen|V0004|2199|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2209||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16004|22784|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16004||16004|22784||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|44564|40848|lyfalmen|V0342|7314|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||30286||30286|40848||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|54161|69020|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||54161||54161|69020||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1067|2097|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1067||1067|2097||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1607|3288|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1607||1607|3288||1 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997|30.04.2015|R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1008|2464|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1008||1008|2464||2 455406|L01XA0101|Cisplatin Strides|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|HAS|0|0|0|100|IKR|1576|2247|lyfsjukr|||2|100|0||LYFIS ehf|Mylan Hospital AS|Cisplatín||1576||1576|2247||2 455501|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.02.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5296|10218|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5296||5296|10218||2 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995|30.04.2015|R|1|0|0|0|G|0|HES|0|0|1|100|DKK|20589|28583|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||20589||20589|28583||1 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|512|1781|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||512||512|1781||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|950|2384|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||950||950|2384||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1861|3638|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1861||1861|3638||1 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|26586|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|26586||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|8046|12151|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||8046||8046|12151||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3123|5375|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3123||3123|5375||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2535|1643|lyfalmen|V0003|1643|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||412||412|1643||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1064|2541|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1064||1064|2541||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|639384|794696|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||639384||639384|794696||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1340|2921|lyfalmen|V0577|2315|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1340||1340|2921||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1270|2824|lyfalmen|V0674|2824|1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1270||1270|2824||2 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|9792|13339|lyfalmen|V0653|13265|1|60|0|30,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8909||8909|13339||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|1162552|1443424|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||1162552||1162552|1443424||1 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|796|1135|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||796||796|1135||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1459|2081|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1459||1459|2081||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|19724|37591|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||19724||19724|37591||2 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7073|10812|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7073||7073|10812||1 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2177|lyfalmen|V0284|2153|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||800||800|2177||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1946|3755|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1946||1946|3755||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3746|6232|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3746||3746|6232||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|7652|11609|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7652||7652|11609||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|226493|282711|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||226493||226493|282711||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|5851|11271|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||5851||5851|11271||2 461006|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.06.2014||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|1089|2575|lyfalmen|||1|2,4|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||1089||1089|2575|28.2.2015|1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|81105|102430|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||81105||81105|102430||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|519584|646144|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||519584||519584|646144||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1871|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1871||2 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|202|1354|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1354||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|559|1846|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||559||559|1846||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|617|1926|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||617||617|1926||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|3495|5887|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||3495|5887||2 462358|A07EA0601|Entocort|endaþ.dr|20|mcg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6133|9518|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6133||6133|9518||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|15477|22117|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||15477||15477|22117||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6233|11996|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||6233|11996||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1665|lyfalmen|V0108|1665|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1665||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|16642|6458|lyfalmen|V0605|6261|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||3910||3910|6458||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4972|9603|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4972||4972|9603||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|657|937|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||657||657|937||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|53741|68499|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||53741|68499||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2773|4893|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2773||2773|4893||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1821|3583|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1821||1821|3583||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|2782|4905|lyfalmen|V0376|4905|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2782||2782|4905||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1104|2170|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1104||1104|2170||1 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1118|2197|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1118||1118|2197||1 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3427|5793|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3427||3427|5793||2 465472|M05BA0803|Zoledronic acid Actavis|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|10386|14739|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||10386||10386|14739||1 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|2177|lyfalmen|V0038|2177|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2177||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3829|lyfalmen|V0039|3829|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||2000||2000|3829||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|620|1930|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||620||620|1930||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2279|4213|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2279||2279|4213||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1201|2729|lyfalmen|V0545|2016|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1201|2729||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1374|2967|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1374||1374|2967||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4762|7631|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4762||4762|7631||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|262997|327976|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||262997||262997|327976||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|19484|27185|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||19484||19484|27185||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2555|4593|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2555||2555|4593||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7359|11205|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7359||7359|11205||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4203|6861|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4203||4203|6861||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|3696|6163|lyfalmen|V0063|4852|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||3696||3696|6163||1 467432|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8544|16380|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8544||8544|16380||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6379|9096|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6379||6379|9096||2 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001|31.03.2015|R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17631|23001|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17049||17049|23001||1 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|14357|20701|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||14357||14357|20701||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|6970|10670|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||6970||6970|10670||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|27337|37118|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||27337||27337|37118||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|10514|15548|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||10514||10514|15548||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|83554|105467|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||83554||83554|105467||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|429|612|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||429||429|612||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5958|6389|lyfalmen|V0317|2560|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3860||3860|6389||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|289|412|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||289||289|412||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8675|6097|lyfalmen|V0318|2177|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3648||3648|6097||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2190|3775|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2190||2190|3775||2 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|374|533|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||374||374|533||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2310|lyfalmen|V0207|2310|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2310||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5808|11189|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||5808||5808|11189||2 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5200|lyfalmen|V0467|4380|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5200||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5238|8286|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5238||5238|8286||1 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11270|6991|lyfalmen|V0253|6532|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4297||4297|6991||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7053|10058|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7053||7053|10058||2 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5866|9150|lyfalmen|V0228|8754|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5866||5866|9150||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|2343|3641|lyfalmen|V0037|3641|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1863||1863|3641||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4770|7642|lyfalmen|V0227|6897|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4770||4770|7642||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3114|5362|lyfalmen|V0226|4742|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3114||3114|5362||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|10064|9325|lyfalmen|V0622|9325|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5993||5993|9325||1 470352|M05BA0804|Zoledronic acid medac|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|13566|18682|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13566||13566|18682||2 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5018|7983|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5018||5018|7983||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|25262|33185|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||25262||25262|33185||1 470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4172|8086|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4172||4172|8086||2 471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1035|2034|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1035||1035|2034||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1132|2634|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||1132||1132|2634||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5514|8666|lyfalmen|V0156|8666|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5514||5514|8666||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4426|8568|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4426||4426|8568||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1857|3632|lyfalmen|V0048|2465|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1857||1857|3632||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3351|5689|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3351||3351|5689||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|11674|16336|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||11674||11674|16336||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|9141|5371|lyfalmen|V0012|5167|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4270|6954|lyfalmen|V0458|4085|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4270||4270|6954||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|3088|5327|lyfalmen|V0670|4511|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||3088||3088|5327||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|10867|15335|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||10867||10867|15335||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|2609|3720|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2609||2609|3720||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1640|3334|lyfalmen|V0677|3334|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1640||1640|3334||1 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|28263|53791|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||28263||28263|53791||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|29893|11940|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||7893||7893|11940||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|745|2102|lyfalmen|V0266|2100|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||745||745|2102||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2590|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2590||1 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2760|4875|lyfalmen|||1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||2760||2760|4875||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|497|1760|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||497||497|1760||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|627|1939|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||627||627|1939||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|IKR|1486|3122|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||1486||1486|3122||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2712|4809|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2712||2712|4809||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3537|5945|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3537||3537|5945||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|61533|78161|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||61533|78161||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2654|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2654||1 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|17064|24125|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||17064||17064|24125||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5518|8671|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5518||5518|8671||1 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|38026|lyfalmen|V0272|38026|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||28055||28055|38026||2 477382|N05AH0410|Quetiapin Actavis|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|33797|39623|lyfalmen|V0272|38026|2|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||29318||29318|39623||1 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|892|2304|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||892||892|2304||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 477941|L01XX4401|Zaltrap|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|47400|60636|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||47400||47400|60636||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|446|1656|lyfalmen|V0500|1656|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||421||421|1656||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|7072|13587|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||7072||7072|13587||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|25723|35076|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||25723||25723|35076||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|113761|142924|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||113761||113761|142924||1 480223|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4990|8601|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||4990||4990|8601||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|15230|7463|lyfalmen|V0341|7314|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4640||4640|7463||2 480932|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|19568|27292|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||19568||19568|27292||1 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|14876|21357|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14876||14876|21357||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|735|2088|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||735||735|2088||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4546|7333|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International|Olodaterol||4546||4546|7333||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|295|1482|lyfalmen|V0055|1347|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||295||295|1482||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15144|21696|lyfalmen|V0641|21696|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15144||15144|21696||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|63886|81079|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||63886||63886|81079||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|35868|47908|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||35868|47908||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6145|8763|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6145||6145|8763||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1800|2453|lyfalmen|V0467|2453|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2453||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2577|3675|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2577||2577|3675||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6315|9768|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6315||6315|9768||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4448|6343|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4448||4448|6343||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2253|4177|lyfalmen|V0374|4177|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2253||2253|4177||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|891|2303|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||891||891|2303||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|271|1347|lyfalmen|V0055|1347|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||197||197|1347||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|53158|67776|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||53158||53158|67776||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5524|8680|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||5524||5524|8680||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|125473|157447|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||125473||125473|157447||1 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1222|2758|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||1222||1222|2758||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|10950|16148|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||10950||10950|16148||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|51030|67085|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||51030||51030|67085||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1158|2670|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1158||1158|2670||1 485252|L01CD0202|Docetaxel Actavis|irþ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8302|11839|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8302||8302|11839||1 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|380669|473890|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Riociguatum||380669||380669|473890||2 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13560|19693|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13560||13560|19693||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|93043|117233|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Dolutegravír||93043||93043|117233||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|529|1804|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||529||529|1804||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|755|2116|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||755||755|2116||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|18327|14257|lyfalmen|V0573|14257|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9576||9576|14257||1 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|30714|39945|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||30714||30714|39945||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|51545|65776|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||51545||51545|65776||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|30549|41180|lyfalmen|V0453|41180|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||30549||30549|41180||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1902|lyfalmen|V0469|1902|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1902||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|845|2239|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||845||845|2239||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2349|4309|lyfalmen|V0198|2789|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2349||2349|4309||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|261266|325830|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||261266||261266|325830||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|6283|9724|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6283||6283|9724||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|11154|16429|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11154||11154|16429||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2590|lyfalmen|V0331|2590|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2590||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|7143|10908|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||7143||7143|10908||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|83956|105965|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||83956|105965||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|HES|0|0|1|100|DKK|323|1328|lyfalmen|V0188|497|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||183||183|1328||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|842|1690|lyfalmen|V0188|1491|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||446||446|1690||1 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2114|3986|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2114||2114|3986||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2099|3965|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2099||2099|3965||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4996|7773|lyfalmen|V0133|7773|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4865||4865|7773||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3677|6137|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3677||3677|6137||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10064|10055|lyfalmen|V0112|2728|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6523||6523|10055||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4889|7806|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4889||4889|7806||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13282|13577|lyfalmen|V0113|3485|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9082||9082|13577||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15169|16851|lyfalmen|V0114|3485|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11461||11461|16851||1 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0665|30351|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33293|43143|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33293|43143||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|125896|157971|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||125896|157971||1 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|sk-pokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3492|5883|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3492||3492|5883||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|511922|636643|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||511922||511922|636643||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3051|5276|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3051||3051|5276||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11170|16451|lyfalmen|V0002|5371|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||11170||11170|16451||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16218|23055|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16218||16218|23055||1 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|25964|35381|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||25964||25964|35381||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11147|16419|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||11147||11147|16419||1 493401|R03DC0305|Montelukast Navamedic|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6589|5768|lyfalmen|V0492|3497|2|98|0|39,2000|Artasan ehf|Navamedic ASA|Montelúkast||3409||3409|5768||1 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.12.2011|28.02.2015|R|1|0|0|0|0|0|APC|0|0|0|100|XEU|18429|5883|lyfalmen|||2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3492||3492|5883||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1133|2636|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1133||1133|2636||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2293|4232|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2293||2293|4232||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|67133|85105|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||67133||67133|85105||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|167832|209972|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||167832||167832|209972||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|343661|428000|lyfsjukr|||1|7|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||343661|428000||1 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1872|3653|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1872||1872|3653||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2099|3965|lyfalmen|V0128|2089|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2099||2099|3965||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3051|5276|lyfalmen|V0410|4509|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3051||3051|5276||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2052|4033|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|||2052||2052|4033||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1697|3412|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1697||1697|3412||1 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|19831|6788|lyfalmen|V0384|5568|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4150||4150|6788||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|7713|6910|lyfalmen|V0382|6124|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4238||4238|6910||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5996|9329|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||5996||5996|9329||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3026|5241|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||3026||3026|5241||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33490|lyfalmen|V0345|33490|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33490||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4254|8241|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4254||4254|8241||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|11849|4016|lyfalmen|V0572|4016|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||2136||2136|4016||1 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|74741|94539|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||74741||74741|94539||3 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|486|1745|lyfalmen|V0643|1745|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||486||486|1745||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|436|1676|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||436||436|1676||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|787|2160|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||787||787|2160||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|183757|229719|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||183757||183757|229719||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|230686|287911|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||230686||230686|287911||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1663|3151|lyfalmen|V0127|3151|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1507||1507|3151||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3000|5206|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3000||3000|5206||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|824|2210|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||824||824|2210||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1992|lyfalmen|V0056|1992|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|317|1513|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||317||317|1513||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|607|1912|lyfalmen|V0448|1912|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||607||607|1912||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1309|2469|lyfalmen|V0449|2469|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1012||1012|2469||1 497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1621|3186|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1621||1621|3186||2 497983|N04BC0407|Ropinirol Actavis|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14027|10308|lyfalmen|V0533|10308|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||6707||6707|10308||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1402|2951|lyfalmen|V0369|2951|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíð||1362||1362|2951||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|3829|lyfalmen|V0472|3829|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15759|22474|lyfalmen|V0608|15966|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15759||15759|22474||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16811|23805|lyfalmen|V0609|19430|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16811||16811|23805||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20940|29027|lyfalmen|V0610|19229|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||20940||20940|29027||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|25298|34539|lyfalmen|V0611|25377|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||25298||25298|34539||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1041|2509|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1041||1041|2509||1 499109|N05AH0410|Quetiapin Actavis|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12188|16452|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||11171||11171|16452|31.3.2015|1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0664|30351|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10287|15235|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10287|15235||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5830|9101|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5830||5830|9101||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11993|17583|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||11993||11993|17583||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3861|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|3861||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5724|8955|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5724||5724|8955||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BGB|0|0|0|100|DKK|26235|35724|lyfalmen|||1|168|0|42,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||26235||26235|35724||2 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2845|4992|lyfalmen|V0434|4727|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2845||2845|4992||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|19454|25983|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||19454||19454|25983||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0665|30351|1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6799|8313|lyfalmen|V0354|8313|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8313||2 503795|M01AB0512|Voltaren Dolo|húðuðtfl|25|mg|20|stk|1|þpakki||M01AB05|01.10.2011|28.02.2015|L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 504014|N04BC0407|Ropinirol Actavis|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|27476|20452|lyfalmen|V0534|20452|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||14160||14160|20452||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4006|5713|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4006||4006|5713||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1541|2669|lyfalmen|V0494|2617|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríð||1157||1157|2669||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|8122|12255|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||8122||8122|12255||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1897|3687|lyfalmen|||1|90|0|45,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1897||1897|3687||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1079|2561|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1079||1079|2561||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13013|24859|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||13013||13013|24859||1 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|7829|11852|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||7829||7829|11852|31.3.2015|1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1677|2391|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1677||1677|2391||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3349|4776|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3349||3349|4776||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7643|10899|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7643||7643|10899||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0664|30351|1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2330|4283|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2330||2330|4283||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2290|4228|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2290||2290|4228||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|372|1588|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||372||372|1588||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|612|1055|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||612||612|1055||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|119981|150636|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||119981||119981|150636||1 507367|A10BX0205|Repaglinide Accord|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.04.2014|31.03.2015|R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|||lyfalmen|||2|90|0|11,2500|Portfarma ehf|Accord Healthcare Limited|Repaglíníð||||||| 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9748|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9748||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5350|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5350||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1875|3657|lyfalmen|V0092|3657|2|100|0|66,6600|Portfarma ehf|Orion Corporation|Spírónólaktón||1875||1875|3657||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|9400|13464|lyfalmen|V0687|13464|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||9000||9000|13464||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1851|lyfalmen|V0555|1851|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1851||1 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2376|4347|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2376||2376|4347||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4749|9180|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4749|9180||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4278|8287|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4278||4278|8287||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12675|24218|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12675||12675|24218||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|598199|743627|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||598199||598199|743627||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8451|12708|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8451||8451|12708||1 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2798||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2045|3891|lyfalmen|V0134|3086|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2045||2045|3891||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|51292|65462|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||51292||51292|65462||1 509696|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|28|stk|1|þpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1800|1751|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Olanzapín||490||490|1751||2 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|81893|103407|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||81893|103407||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|15463|21034|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||15463||15463|21034||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|23146|30561|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||23146||23146|30561||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|37967|48939|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||37967||37967|48939||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|58682|74626|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||58682||58682|74626||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|447|1692|lyfalmen|V0601|1536|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||447||447|1692||1 510608|L01XX4401|Zaltrap|irþ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|94800|119412|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||94800||94800|119412||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|153354|192019|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||153354|192019||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3882|4703|lyfalmen|V0445|4703|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||2635||2635|4703||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2502|4520|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2502||2502|4520||1 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|20691|27517|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||20691||20691|27517||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|12943|17909|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||12943||12943|17909||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|15905|22659|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||15905||15905|22659||2 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|þpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2305|lyfalmen|||2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||893||893|2305|28.2.2015|2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4883|6963|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||4883||4883|6963||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1992|lyfalmen|V0057|1992|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1992||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1795|lyfalmen|V0109|1795|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1795||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|21220|29381|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||21220||21220|29381||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2501|4915|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2501||2501|4915||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1974|3880|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1974||1974|3880||2 513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9870|18896|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9870||9870|18896||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1624|3312|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1624||1624|3312||1 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|þpakki||C07AG02|01.07.2011|31.03.2015|R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3699|6168|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Group PTC ehf|Carvedílól||3699||3699|6168||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19080|26674|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||19080|26674||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|5206|lyfalmen|V0692|5206|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3000||3000|5206||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4340|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4340||1 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0149|2563|0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2563||1 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0150|2575|0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2575||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|14348|20689|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||14348||14348|20689||3 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4994|6132|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4300||4300|6132||1 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|24044|lyfalmen|V0273|24044|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||17000||17000|24044||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2745|4855|lyfalmen|V0462|2872|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2745||2745|4855||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|32422|43549|lyfalmen|V0662|43549|1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||32422||32422|43549||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2989|5190|lyfalmen|V0471|2872|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2989||2989|5190||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3214|5500|lyfalmen|V0472|2872|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3214||3214|5500||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|31886|41399|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||31886||31886|41399||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|1011|2468|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1011||1011|2468||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3210|5495|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3210||3210|5495||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1937|3742|lyfalmen|V0590|3082|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1937||1937|3742||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1180|2199|lyfalmen|V0004|2199|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||816||816|2199||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|17896|25177|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||17896||17896|25177||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|980|2425|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||980||980|2425||1 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3712|6186|lyfalmen|V0644|6186|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3712||3712|6186||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1468|3097|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1468||1468|3097||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|6747|10363|lyfalmen|||2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6747||6747|10363||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7904|4082|lyfalmen|V0515|4082|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2184||2184|4082||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|22190|30608|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||22190|30608||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4473|7233|lyfalmen|V0141|4197|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4473||4473|7233||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5051|8029|lyfalmen|V0143|1467|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5051||5051|8029||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14232|20543|lyfalmen|V0143|4402|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14232||14232|20543||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5417|8532|lyfalmen|V0144|1637|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5417||5417|8532||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14989|21500|lyfalmen|V0144|4912|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14989||14989|21500||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2040|lyfalmen|V0056|1992|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2040|lyfalmen|V0057|1992|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2040||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|316|1511|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||316||316|1511||1 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0135|1763|0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1763||1 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0136|1773|0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1773||1 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|29792|40223|lyfalmen|V0269|24668|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||29792||29792|40223||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8991|17228|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||8991||8991|17228||1 522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10818|15966|lyfalmen|V0608|15966|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||10818||10818|15966||1 522599|J07CA0202|Tetravac|stl|||0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2128|4005|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||2128||2128|4005||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|163950|205158|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||163950||163950|205158||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2572|4616|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2572||2572|4616||1 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998|30.04.2015|R|0|0|1|0|G|0|GLP|0|0|1|100|DKK|370|1586|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||370||370|1586||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2354|4316|lyfalmen|V0192|4316|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2354||2354|4316||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|982|2428|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||982||982|2428||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5424|4369|lyfalmen|V0285|4369|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2392||2392|4369||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1495||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|305231|380346|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||305231||305231|380346||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1049|2520|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1049||1049|2520||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1652|3350|lyfalmen|V0584|3350|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1652||1652|3350||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|395|1620|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||395||395|1620||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2273|4205|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2273||2273|4205||1 524257|L02BB0001|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|455166|566266|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||455166||455166|566266||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6080|lyfalmen|V0010|3617|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6080||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1765|3469|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1765||1765|3469||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|652|1974|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||652||652|1974||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|718|2065|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||718||718|2065||1 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1598|3276|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1598||1598|3276||1 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4630|7449|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4630||4630|7449||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|6945|8743|lyfalmen|V0657|8234|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||5570||5570|8743||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|13091|22564|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||13091||13091|22564||2 525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|17653|6261|lyfalmen|V0605|6261|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||3767||3767|6261||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|36599|48832|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||36599|48832||2 525757|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|glas||C10AA07|01.03.2014||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13058|19058|lyfalmen|V0117|7919|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13058||13058|19058||1 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5050|7201|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríð||5050||5050|7201||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4597|6555|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríð||4597||4597|6555||1 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 526367|N02BE0119|Therimin Honung & Citron|mixtduft|500|mg|10|sk-pokar|1|pakki||N02BE01|01.01.2015||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|16,6700|Artasan ehf|Novartis Healthcare A/S|Paracetamól|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4140|6775|lyfalmen|V0435|6775|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4140||4140|6775||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3866|6397|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3866||3866|6397||1 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3307|5628|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3307||3307|5628||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|12680|17583|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||12680||12680|17583||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|17634|5675|lyfalmen|V0516|5446|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3341||3341|5675||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1399|3002|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1399||1399|3002||1 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|985|1982|lyfalmen|V0046|1982|2|100|0|33,3333|Portfarma ehf|Orion Corporation|Spírónólaktón||658||658|1982||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|16800|20502|lyfalmen|V0635|20502|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||14200||14200|20502||2 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10692|6536|lyfalmen|V0011|5228|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3967||3967|6536||1 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15741|22451|lyfalmen|V0641|21696|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15741||15741|22451||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2110|3981|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||2110||2110|3981||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|6427|9922|lyfalmen|V0356|8715|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||6427||6427|9922||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6384|9863|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6384||6384|9863||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|8817|5272|lyfalmen|V0621|5272|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||3048||3048|5272||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4172|8086|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4172||4172|8086||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4435|8585|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4435||4435|8585||2 529449|A02BC0112|Omezolmyl|sþ-hylki|40|mg|98|stk|1|þpakki||A02BC01|01.09.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|9215|3107|lyfalmen|V0001|3022|2|98|0|196,0000|Icepharma hf|Mylan AB|Ómeprazól||1475||1475|3107||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|63678|80821|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||63678||63678|80821||1 529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2012|31.03.2015|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|||lyfalmen|||2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||||||| 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1865|3665|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1865||1865|3665||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10023|lyfalmen|V0194|10023|2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10023||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6157|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6572||1 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|þpakki||L02BG03|01.03.2012|31.03.2015|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|11187|2337|lyfalmen|V0186||2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||916||916|2337||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1518|2983|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1518||1518|2983||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2796|4925|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2796||2796|4925||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5536|7894|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5536||5536|7894||2 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2635|4703|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2635||2635|4703||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|4708|6714|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||4708||4708|6714||3 531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1765|lyfalmen|V0329|1765|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1765||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|583|1879|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||583||583|1879||1 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010|30.04.2015|R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|312|1506|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||312||312|1506||1 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010|31.03.2015|R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|902|2318|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||902||902|2318||1 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|247|1416|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||247||247|1416||1 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1575|3244|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1575||1575|3244||1 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2042|2912|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2042||2042|2912||2 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1786|3535|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1786||1786|3535||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17363|24503|lyfalmen|V0639|24503|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17363||17363|24503||1 534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|þpakki||N05AH03|01.02.2013|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14774|21228|lyfalmen|||2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||14774||14774|21228||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|54505|71480|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||54505||54505|71480||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2005|3941|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2005||2005|3941||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|7958|lyfalmen|V0117|7919|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5000||5000|7958||2 534652|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.05.2014||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3010|4288|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3007||3007|4288||1 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5474|7806|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5474||5474|7806||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2504|4523|lyfalmen|V0092|3657|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2504||2504|4523||1 535446|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|5205|8240|lyfalmen|V0585|8240|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||5205||5205|8240||1 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|493|1755|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||493||493|1755||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|629|1942|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||629||629|1942||1 536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.11.2011|31.03.2015|R|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyfalmen|||2|100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||||||| 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|þpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|377|1442|lyfalmen|V0502|860|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||266||266|1442||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|27715|36227|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||27715||27715|36227||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|95743|123638|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||95743||95743|123638||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2737|3903|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2737||2737|3903||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5652|8060|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5652||5652|8060||2 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2414||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0135|1763|0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1763||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|109454|137583|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||109454||109454|137583||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3328|3416|lyfalmen|V0678|3416|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan||1700||1700|3416||2 538794|N05AH0412|Quetiapin Sandoz|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|31744|39110|lyfalmen|V0272|38026|2|100|0|75,0000|Artasan ehf|Sandoz A/S|Quetíapín||28912||28912|39110||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|7246|11050|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7246||7246|11050||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|589|1887|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||589||589|1887||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|595|1895|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||595||595|1895||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1667|3371|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1667||1667|3371||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20362|27109|lyfsjukr|||1|2958|0||Icepharma hf|Fresenius Kabi|Blöndur||20362||20362|27109||2 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2589|4640|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2589||2589|4640||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|3177|3229|lyfalmen|V0621|1757|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||1564||1564|3229||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2401|4138|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2401||2401|4138||2 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5462|8594|lyfalmen|V0373|7021|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5462||5462|8594||1 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12165|7463|lyfalmen|V0341|7314|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4640||4640|7463||2 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188972|236185|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188972||188972|236185||2 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5469|7799|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5469||5469|7799||1 542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|13193|19229|lyfalmen|V0610|19229|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13193||13193|19229||1 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|584|1880|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||584||584|1880||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|15388|22005|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||15388|22005||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3538|2790|lyfalmen|V0203|2790|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1245||1245|2790||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2700|4793|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2700||2700|4793||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2062|3115|lyfalmen|V0373|2340|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1481||1481|3115||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|72671|91972|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||72671|91972||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 543755|R03DC0305|Montelukast Navamedic|töflur|10|mg|98|stk|1|þpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6779|2522|lyfalmen|V0490|2288|2|98|0|98,0000|Artasan ehf|Navamedic ASA|Montelúkast||1050||1050|2522||1 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|þpakki|hörð|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|441386|549179|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||441386||441386|549179||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4081|4458|lyfalmen|V0143|4402|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2457||2457|4458||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|252905|315462|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||252905||252905|315462||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12105|17852|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12105||12105|17852||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|50000|43016|lyfalmen|V0636|43016|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||32000||32000|43016||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|241067|300783|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||241067||241067|300783||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1797|3086|lyfalmen|V0134|3086|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1460||1460|3086||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1044|2513|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1044||1044|2513||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|840|2232|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||840||840|2232||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2074|3931|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2074||2074|3931||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28072|38047|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||28072||28072|38047||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22633|31168|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||22633||22633|31168||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|28237|38256|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||28237||28237|38256||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23989|32883|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||23989||23989|32883||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1279|2837|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1279||1279|2837||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2728|lyfalmen|V0580|2728|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2728||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4021|3691|lyfalmen|V0010|3691|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1900||1900|3691||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4912||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2453|lyfalmen|V0004|2199|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10953|15442|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10953||10953|15442||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3522|5022|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3522||3522|5022||1 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|99126|124776|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||99126||99126|124776||2 548154|N06DX0103|Nemdatine|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|36007|13134|lyfalmen|V0607|13134|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||8760||8760|13134||1 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1077|2559|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1077||1077|2559||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||1726||1 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|156841|196343|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||156841||156841|196343||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8415|12659|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||8415||8415|12659||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|11815|6864|lyfalmen|V0606|5123|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||4205||4205|6864||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|35868|47908|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||35868|47908||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ aðsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2497|4038|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefnavakar||2152||2152|4038||1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1748|lyfalmen|V0551|1723|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1748||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3475|3829|lyfalmen|V0471|3829|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2000||2000|3829||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2237|4155|lyfalmen|V0122|4155|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2237||2237|4155||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8032|11454|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||8032||8032|11454||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|7960|12032|lyfalmen|V0235|12032|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||7960||7960|12032||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1622|3309|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1622||1622|3309||1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2596|4649|lyfalmen|V0198|4649|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2596||2596|4649||1 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2092|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||738||738|2092||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1854|lyfalmen|V0466|1782|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3544|lyfalmen|V0467|2453|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1105|lyfalmen|V0003|822|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1105||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1854|lyfalmen|V0003|1643|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1854||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3544|lyfalmen|V0010|2067|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3544||1 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|17634|5675|lyfalmen|V0516|5446|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3341||3341|5675||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1407|2006|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1407||1407|2006||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|18735|30201|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||18735||18735|30201||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3056|5283|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3056||3056|5283||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11148|16420|lyfalmen|V0237|16420|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11148|16420||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3300|2728|lyfalmen|V0112|2728|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1200||1200|2728||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3812|6323|lyfalmen|V0237|5473|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3812||3812|6323||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|519584|646144|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||519584||519584|646144||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|41743|53621|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||41743|53621||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10706|20482|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||10706||10706|20482||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7785|6627|lyfalmen|V0029|6627|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4033||4033|6627||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2110|3981|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2110||2110|3981||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2405|4387|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2405||2405|4387||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1815|3574|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1815||1815|3574||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|551983|686319|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||551983||551983|686319||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|13688|17837|lyfalmen|V0440|17837|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||12093||12093|17837||1 556556|D07AC0104|Diproderm|húðlausn|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2092|3956|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2092||2092|3956||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|20169|26870|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||20169||20169|26870||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4528|7309|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4528||4528|7309||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8828|13227|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8828||8828|13227||1 557546|D10AF0202|Zineryt|áburður|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1486|3122|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1486||1486|3122||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2672|4501|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2488||2488|4501||2 558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4230|8196|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4230||4230|8196||2 558335|C07AG0204|Carvedilol HEXAL|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.01.2015||R|1|0|0|0|G|0|PCO|0|0|0|100|DKK|2459|4461|lyfalmen|||2|100|1|33,3300|Distica|Distica - óskráð lyf|Carvedílól||2459||2459|4461||1 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|227916|284476|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||227916|284476||1 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1805|3561|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1805||1805|3561||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1455|3079|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1455||1455|3079||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5317|8395|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5317||5317|8395||1 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|3099|5342|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3099||3099|5342||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1491||1 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1765|lyfalmen|V0067|1765|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1765||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1546|2846|lyfalmen|V0044|2293|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1286||1286|2846||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1624|3312|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1624||1624|3312||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6219|9636|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6219||6219|9636||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6744|10359|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6744||6744|10359||1 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|91168|114908|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||91168||91168|114908||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|419374|521884|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||419374||419374|521884||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|158489|139874|lyfsjukr|||2|60|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||111302||111302|139874||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1597|3274|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1597||1597|3274||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BGB|0|1|0|100|DKK|188972|236185|lyfsjukr|||1|42|0||Icepharma hf|Bayer Pharma AG|Riociguatum||188972||188972|236185||2 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1833|2634|lyfalmen|V0098|2396|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1132||1132|2634||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|46248|59208|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||46248||46248|59208||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4404|7138|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4404||4404|7138||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|217587|271668|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||217587||217587|271668||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|97577|122855|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||97577||97577|122855||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|106593|137361|lyfalmen|||1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||106593||106593|137361||2 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|751|2110|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||751||751|2110||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|726|2076|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||726||726|2076||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1283|2842|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1283||1283|2842||1 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3333|5664|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3333||3333|5664||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3455|5832|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3455||3455|5832||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|431068|547757|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||431068||431068|547757||1 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.07.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2323|2311|lyfalmen|V0207|2310|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||897||897|2311||2 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|10580|18236|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10580||10580|18236||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1392|2621|lyfalmen|V0596|1854|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1122||1122|2621||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|64695|82082|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||64695||64695|82082||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1025|2487|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1025||1025|2487||1 564931|L01XA0210|Carboplatin Hospira|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.03.2015||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1283|1830|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1283||1283|1830||2 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|8647|lyfalmen|V0286|6382|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||5500||5500|8647||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|10726|15840|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||10726||10726|15840||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8040|15424|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8040|15424||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|22787|30116|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||22787||22787|30116||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1562|3226|lyfalmen|V0444|2473|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||1562||1562|3226||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|3497|5890|lyfalmen|V0193|5890|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||3497||3497|5890||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13753|19937|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13753||13753|19937||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|220473|275247|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||220473||220473|275247||1 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16131|22944|lyfalmen|V0651|22944|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16131||16131|22944||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5391|8496|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5391|8496||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2976|5172|lyfalmen|V0291|2315|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2976||2976|5172||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3463|5843|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3463||3463|5843||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6023|9366|lyfalmen|V0292|3760|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6023||6023|9366||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1167|2683|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1167||1167|2683||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5497|8642|lyfalmen|V0663|8642|1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5497||5497|8642||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2702|3975|lyfalmen|V0058|3554|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2106||2106|3975||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3744|5427|lyfalmen|V0059|4930|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3161||3161|5427||1 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|151453|189662|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||151453||151453|189662||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|10982|15478|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10982||10982|15478||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|14289|19578|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14289||14289|19578||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|16432|22236|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16432||16432|22236||1 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3149|6145|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3149||3149|6145||1 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|76881|97192|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||76881||76881|97192||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|41742|53620|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||41742|53620||3 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|506713|630184|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||506713||506713|630184||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|78237|101496|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||78237||78237|101496||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8127|5371|lyfalmen|V0011|5123|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5371||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3504|lyfalmen|V0245|3483|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3504||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4008|6593|lyfalmen|V0464|5295|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||4008||4008|6593||1 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993|30.04.2015|R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2908|5079|lyfalmen|||1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||2908||2908|5079||1 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|34744|19289|lyfalmen|V0607|12871|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||13241||13241|19289||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|79657|100635|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||79657||79657|100635||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|15786|21435|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||15786||15786|21435||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|25881|33952|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||25881||25881|33952||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2365|2689|lyfalmen|V0189|2125|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1172||1172|2689||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5415|4977|lyfalmen|V0144|4912|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2834||2834|4977||2 574377|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.09.2013||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|39589|50950|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||39589|50950||1 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|388133|483145|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||388133||388133|483145||2 574900|N05AH0410|Quetiapin Actavis|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|21244|25836|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||18417||18417|25836|30.4.2015|1 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2297|2129|lyfalmen|V0151|1647|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||765||765|2129||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|7157|6641|lyfalmen|V0322|2296|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4043||4043|6641||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4237|2129|lyfalmen|V0152|2124|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||765||765|2129||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|13029|6698|lyfalmen|||1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4084||4084|6698|30.4.2015|1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1541|2140|lyfalmen|V0159|2078|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||773||773|2140||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1648|2549|lyfalmen|V0160|2524|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1070||1070|2549||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1556|2453|lyfalmen|V0158|2453|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1000||1000|2453||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1539|lyfalmen|V0243|1367|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1539||1 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|11921|17484|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||11921||11921|17484||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|3485|lyfalmen|V0113|3485|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3485||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11827|16525|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11827||11827|16525||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|6423|11071|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||6423||6423|11071||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1143|2650|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1143||1143|2650||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4212|2453|lyfalmen|V0005|2440|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2453||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|339|1543|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||339||339|1543||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|8046|6653|lyfalmen|V0107|6444|2|30|0|15,0000|Portfarma ehf|Portfarma ehf|Eplerenón||4052||4052|6653||2 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|25182|lyfalmen|V0111|25153|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17900||17900|25182||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|693|2030|lyfalmen|V0675|2030|1|10|0||Icepharma hf|Bayer AB|Flúókortólón||693||693|2030||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7956|12027|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7956||7956|12027||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1629|2323|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1629||1629|2323||2 581619|N03AX1407|Levetiracetam Teva|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.03.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|5500|6582|lyfalmen|V0253|6532|2|100|0|33,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||4000||4000|6582||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3380|5729|lyfalmen|V0620|5729|2|6|0|3,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||3380||3380|5729||2 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2801|3306|lyfalmen|||3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníð||1620||1620|3306|31.3.2015|2 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|13398|25589|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13398||13398|25589||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2608|4666|lyfalmen|V0669|4161|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2608||2608|4666||1 581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6440|12388|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6440||6440|12388||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|20343|27085|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||20343||20343|27085||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|39810|51224|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||39810||39810|51224||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|20742|28776|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||20742||20742|28776||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|79619|100588|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||79619||79619|100588||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26114|34241|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||26114||26114|34241||2 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999|31.03.2015|R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|4590|7911|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||4590||4590|7911||2 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999|31.03.2015|R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|17833|30737|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||17833||17833|30737||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29957|39007|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||29957||29957|39007||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|68022|86207|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||68022||68022|86207||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26555|34788|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||26555||26555|34788||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|33075|42873|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||33075||33075|42873||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2366|3687|lyfalmen|V0376|1635|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1897||1897|3687||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|54249|69129|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||54249||54249|69129||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|974|2417|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||974||974|2417||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|91614|115461|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||91614||91614|115461||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29025|37851|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||29025||29025|37851||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|46439|59444|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||46439||46439|59444||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|87074|109832|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||87074||87074|109832||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|180835|226095|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||180835||180835|226095||1 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17183|23167|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17183||17183|23167||1 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1639|3332|lyfalmen|V0064|2741|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíð||1639||1639|3332||1 584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1606|2190|lyfalmen|V0143|1467|2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||809||809|2190||2 585130|N06DA0301|Exelon|forðapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|40006|53142|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||40006||40006|53142||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5635|8832|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5635||5635|8832||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4182|5964|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4182||4182|5964||1 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4728|7584|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4728||4728|7584||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|þpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|436|1469|lyfalmen|V0541|1469|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||285||285|1469||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|30172|40704|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||30172||30172|40704||1 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1613|3296|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1613||1613|3296||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|13157|18175|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13157||13157|18175||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|350832|436892|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||350832||350832|436892||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11304|5195|lyfalmen|V0606|5123|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||2992||2992|5195||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|27357|37143|lyfalmen|V0652|37019|1|168|0|168,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||27357|37143||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|11200|14674|lyfalmen|V0196|14674|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||9879||9879|14674||1 587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18086|25417|lyfalmen|V0611|25377|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||18086||18086|25417||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4940|3021|lyfalmen|V0604|2970|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||1413||1413|3021||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|147611|184898|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||147611||147611|184898||1 587613|A02BC0112|Omezolmyl|sþ-hylki|40|mg|100|stk|1|þpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|6620|3084|lyfalmen|V0001|3084|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1459||1459|3084||2 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9391|5141|lyfalmen|V0095|4947|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||2953||2953|5141||1 588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|32199|13333|lyfalmen|V0607|12871|2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||8905||8905|13333||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2026|3865|lyfalmen|V0461|3864|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2026||2026|3865||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|7950|12019|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||7950||7950|12019||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21987|30351|lyfalmen|V0668|30351|1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21987||21987|30351||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8703|5255|lyfalmen|V0282|4271|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3036||3036|5255||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7683|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7683||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|775034|962902|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||775034||775034|962902||1 589358|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5650|9738|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5650||5650|9738||2 589366|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2190|3775|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2190||2190|3775||2 589374|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5451|9395|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5451||5451|9395||2 589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2944|5074|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2944||2944|5074||2 589390|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3058|5271|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3058||3058|5271||2 589408|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2941|5069|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2941||2941|5069||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11586|16227|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||11586||11586|16227||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|126403|158600|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||126403||126403|158600||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2850|3219|lyfalmen|V0041|2671|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1557||1557|3219||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|158167|197987|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||158167||158167|197987||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12009|17731|lyfalmen|V0347|17731|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12009||12009|17731||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|25182|lyfalmen|V0111|25153|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||17900||17900|25182||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|8717|13074|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||8717||8717|13074||2 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14152|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14152||2 592687|A02BC0112|Omezolmyl|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.09.2013||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2515|2281|lyfalmen|||2|28|0|56,0000|Icepharma hf|Mylan AB|Ómeprazól||875||875|2281||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|703584|874304|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||703584||703584|874304||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|22041|29191|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||22041|29191||3 593379|A10BG0304|Pioglitazone Accord|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|11839|14257|lyfalmen|V0573|14257|2|98|0|98,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||9576||9576|14257||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|479|1736|lyfalmen|V0238|779|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||479||479|1736||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|917|2338|lyfalmen|V0238|2338|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||917||917|2338||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1251|2798|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1251||1251|2798||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|18288|25673|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||18288||18288|25673||1 594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006|31.03.2015|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|||lyfalmen|||2|100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||||||| 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|313|539|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||313||313|539||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5242|7475|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5242||5242|7475||1 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16132|22946|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16132||16132|22946||1 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|21628|28679|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||21628||21628|28679||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|660|1985|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||660||660|1985||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|51277|65443|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||51277|65443||1 596196|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|4|stk|1|þpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|2761|2263|lyfalmen|V0144|1637|2|4|0|8,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||862||862|2263||1 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|15789|21438|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||15789||15789|21438||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2165|4056|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2165||2165|4056||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|597269|742474|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||597269||597269|742474||1 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2747|4857|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2747||2747|4857||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|376|1594|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||376||376|1594||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1788||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|571912|711031|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||571912||571912|711031||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4206|8150|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4206||4206|8150||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2080||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|28557|38661|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||28557|38661||1 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3076|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|3812|6323|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráð lyf|Amfetamín||||3812|6323||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|þpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2448|4446|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||2448||2448|4446||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1737|lyfalmen|||0|3,5|1||Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||480||480|1737||1 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6580|10133|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Kolkisín||6580||6580|10133||2 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|18902|26449|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||18902||18902|26449||2 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3084|5321|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráð lyf|Testósterón||3084||3084|5321||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5009|7971|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráð lyf|Kortisón||5009||5009|7971||1 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|545|1826|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||545||545|1826||2 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1990|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||664||664|1990||2 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4232|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4232||1 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|8004|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|Kortisón||5033||5033|8004||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5009|7971|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráð lyf|Hýdrókortisón||5009||5009|7971||1 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009|31.03.2015|R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4571|7368|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||4571||4571|7368||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|130962|164253|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||130962||130962|164253||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21666|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21666||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4669|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4669||2 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|þpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1257|2806|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Metópímazín||1257||1257|2806||2 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|þpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1430|3045|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1430||1430|3045||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9653|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||6231||6231|9653||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1610|3292|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3292||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1030|2494|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2494||2 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|þpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3707|6179|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Dexklórfeníramín||3707||3707|6179||2 965171|D08AX0001|Bórsýruslím - forskriftarlyf|lausn|2|%|500|ml|1|fl||D08AX|01.04.2014|31.03.2015|R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2340|4297|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis sótthreinsandi lyf||2340||2340|4297||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6146|10593|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||||6146|10593||1 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|12500|3829|lyfalmen|V0286|3829|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||2000||2000|3829||2 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|26953|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|26953||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1522|3171|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3171||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|18870|26409|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|26409||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10802|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10802||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5108|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5108||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6100|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6100||2 969123|L02BA0108|Tamoxifen Aliud|töflur|10|mg|100|stk|1|þpakki||L02BA01|01.03.2014|30.04.2015|R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3348|5685|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Tamoxífen||||3348|5685||2 969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|þpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|2976|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|Karbímazól||1380||1380|2976||2 969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5134|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||2948||2948|5134||2 969412|J01CA0416|Amoxicillin AL|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2014||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2090|3953|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráð lyf|Amoxicillín||||2090|3953||1 969438|J01CA0417|Amoxicillin Sandoz|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.04.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2090|3953|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráð lyf|Amoxicillín||2090||2090|3953||1 969777|N02AA0111|Morfin "DAK"|töflur|10|mg|10|stk|1|þpakki||N02AA01|01.07.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|450|1696|lyfalmen|||0|10|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||450||450|1696||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6565|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6565||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|7951|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|7951||2